Join our mailing list
 
 

Ask the Expert Archive

 
Expand all | Collapse all
Have a question about TRI?
Click here for expert advice!
 
We are planning to institute a same day discharge protocol for elective TRI. The 2009 SCAI paper regarding LOS appears to be too restrictive. What criteria/follow up do you recommend for such patients? By Nitin Chitale, US.   New

We are planning to institute a same day discharge protocol for elective TRI. The 2009 SCAI paper regarding LOS appears to be too restrictive. What criteria/follow up do you recommend for such patients?
By Nitin Chitale, US.

Editorial Board Comments:

Josef Ludwig:

We are not discharging our patients the same day due to internal policy.
Sorry

Tift Mann:

The current SCAI/ACC/AHA guidelines for outpatient stenting are conservative, esp when compared to policies from other institutions around the world. However, they are the established guidelines for the US. I suspect they will evolve with time and more data.

Yves Louvard:

Same answer as Josef Ludwig, reimbursement problem in France.
But a great majority of angio are outpatient ones

Ian Gilchrist:

I send essentially all of my elective PCI's home the same day. Primary criteria is a successful PCI and social (family) support for the night after. I would agree that the SCAI paper is too restrictive, but that was written to satisfy many constituents. I have found that same day discharge is another wonderful thing to do with radial. Patients really appreciate leaving the same day. They get a good night sleep at their own home. Our NP's call them the following day to confirm their discharge instructions and that they have their prescriptions filled. Biggest problem is that once they are done as a same day, they never want to stay over night again. We have done over 300 this way with no re-admissions. Data suggests that this is safe and patient support, once you start sending them home,will give you confidence to continue. In any case, at least in the US, you will no longer get paid for an admission for an elective PCI or at worse be subject to a RAC audit.

Sunil V. Rao:

Agree with Ian. Our protocol is successful radial PCI with no post-PCI chest painor bleeding, live within 60 miles, and have home support. We have only done 5 patients since Jan 2010 when the protocol was instituted, but that is because most of our patients are coming from > 60 miles.

Samir Pancholy:

We have had the same problem with patients traveling long distances to get to the hospital and hence same day discharge has not been a feasible practice in our area.

Mitchell Krucoff:

I am sending elective PCI pts home same day if they are not complicated (simple 1 stent, even bifurcation with good angiographic result) and early cases. The pts monitored for 6 hrs in hospital. I was told payment scale is different between same day (ambulatory), <24 hrs, or >24 hrs. But so far, the hospital has no objection to send elective PCI same day.

Tak

i think the important emphasis is coronary first, access site second, with the caveat that logistically the patient lives close enough and has family at home. and in the USA there is of course the final word: medicolegal.
if the coronary result is complex, mutliple stents or in any way suboptimal, same day d/c is not a good idea.
if the coronary result is simple and excellent, then TRI access site is a clear winner if patient lives nearby and has family.
in USA, medicolegal is safe on any of 3 predicates:
1. standard of community practice
2. in accordance with professional society guidelines
3. established hospital SOP, potentially more advanced than the standard of community practice so bottom line on medicolegal is to at least have an established, written, internally hospital approved SOP....otherwise a single event can be both a personal and programmatic tragedy.

Sasko Aleksandar Kedev:

We are doing outpatient elective PCI since 2007.
Optimal PCI result and the absence of local complications are mandatory for the same day discharge strategy.
We are discussing this issue with patients and families at the admission and after intervention, leaving the opportunity for overnight hospital stay at their preference. No major medical nor legal problem so far.
Best regards,

Tejas & Sanjay:

Out patient PCI is a very good and futuristic concept. However because of the social system our patients and the relatives are not willing to take discharge after PCI on the same day. We have done a pilot study of 123 patients who were sent to their private rooms in the hospital instead of ICCU. They were kept without monitoring and were given the cell no. of the doctor on call. We received only 3 phone calls in 24 hrs of stay. It means that the concept is working well but presently it is unfortunate that we are unable to convince the patients to go home after PCI.

 
Are vasovagal reactions from the actual arterial puncture less likely from the radial than femoral access site? By Ian C. Gilchrist, USA.   

Are vasovagal reactions from the actual arterial puncture less likely from the radial than femoral access site?
By Ian C. Gilchrist, USA.

Editorial Board Comments:

Mitchell Krucoff:

Don’t know of documented numbers but certainly more rare with TRI than with femoral, but still incidence is not zero.

Important to remember to use both saline and atropine as needed, especially in setting where we have given verapamil and/or nitroglycerine to avoid radial spasm.

Actually we routinely monitor HR and BP before sheath insertion, as these parameters are also required documentation for conscious sedation procedures.

This discussion belongs in a larger context: some people vagal at the sight of a needle, or during venipuncture...i think the bottom line is that vagal with TRI is far more rare than with FA, but more than zero.

Josef Ludwig:

I think we making a mouse to become an elephant. To the best of my knowledge-correct me- if I wrong vasovagal reaction is a clinical symptome with feeling bad oale patient cold sweat and drop of bot blood pressure and heart rate. If a.ybidy accuses radial puncture to be the bad boy then he has to look at bot HR and BP before and after punctering. Honestly, who of all the experts messure BP before the arterial sheath is in And can scientifically argue it was rhe puncture or sheath insertion. In my opinion it is not vasovagal it is rather a very vague comment to have frequenty vasovagal reactions. Never saw any in thousand of live cases or during Allens manoever

David Hildicksmith:

I think you all have selective memories. Vasovagal reactions are commoner at the wrist. You can even get them when dowsing the wrist itself with antiseptic in very nervous patients.

OK if you hit the artery cleanly you get no vasovagal, but if you miss and hit something else, vasovagal reactions are commoner. I can't believe any of you is saying anything different!

Yves Louvard:

I have probably datas in one of my very old presentation (94-95 ...)

But things have changed since that time:
- I am more quiet and patients may feel it when doing radial
- sheath are less aggressive
- in France when we work with an anesthetist in the cath lab there is a preliminaryvisit and specific drugs are prescribed ...
- I remember a paper by Peter Ludman showing more pain for the radial ... it was in middle age ...

I agree with David ... without anesthetist in the cath lab this is driven by pain as you know ... Radial approach needs a better preparation of the patient.

Sunil V. Rao:

I have seen this twice, both times in men (we are wimps!). Both times occurred in the setting of the patient being anxious and one of them recurred when navigating a forearm loop. Both resolved quickly with 0.5 mg atropine. We have had several instances of vagal reactions during femoral sheath removal, and none with radial sheath removal. I think it's more common with manual pressure on the femoral artery but I have no data to back that up.

David,
It's interesting that your experience is so different from everyone else. Do you happen to know of any references? It's quite possible that I have attributed any relative hypotension during radial access to sedation or SL TNG, etc. instead of a vagal reaction.

Tak Kwan:

Dear all,
TEJAS's lab uses no sedation! Is any difference?
I also has no recall of the vagal reaction even though there was extreme pain occasionally during shealth removal.

Ian Gilchrist:

It has been my experience that these reactions are lacking at the wrist level although vagal like reactions during acute procedures such as inferior wall MI's still occur. The literature has several references to vagal reactions on the order of 5% in transradial series, but I just have not had that experience and thought I would ask your thoughts/experiences.

James Tift Mann:

Polled the guys that know ie the techs!! 30 techs in 8 labs(both rad and fem): overwhelming majority responded most vagals occur with femoral sheath PULL post cath.

Samir Pancholy:

I do not think anyone has specifically looked at the difference, but in general I have rarely seen true vasovagal reaction from TRA. The couple that I remember are triggered by nitroglycerin and not pain.
I pretreat with Atropine 1 mg before cocktail, if heart rate is less than 45. Although this is not very frequent it may be further lessening the vasovagal trigger.

John Coppola:

I do not believe I have seen a vasovagal reaction I believe the nitro may decrease bp and this quickly reverses with fluid

Olivier F Bertrand:

I have faced some when crossing and straightening loops in the arm, usually associated with some pain I remember also of 1 big guy during radial artery puncture...
Corrected rapidly with 0.5 or 1 mg atropine

Sasko Aleksandar Kedev:

I could not recall on true vasovagal reaction associated with radial artery puncture and sheath removal. There were some vagal like reactions during TRA carotid stenting and RCA reperfusion.

Howard A Cohen:

I have been reading the responses with interest. In my experience I would have to say that I have noted hypotension and bradycardia infrequently, but perhaps more than others have noted it. I think we are dealing with a multi-factorial issue here. I do not believe that there is more pain with TR access, and I am sure that we would all agree that it is clearly more comfortable for the patient from start to finish. I do not believe that I have ever noted a "vaso-vagal" reaction with sheath removal or insertion per se. Remember that all our patients are receiving a spasmolytic cocktail that may accentuate this problem. When hypotension and bradycardia occur, it is after the administration of nitroglycerine and vasodilators. This is more of a problem when the patient has been NPO prior to the procedure and has not been appropriately hydrated prior to coming into the cath lab.
Hydration and pretreatment with atropine would certainly help to avoid this problem. We do not pretreat any patients with atropine as the problem is relatively infrequent. When this does occur, it is readily reversible with the usual measures.

Tejas & Sanjay:

Dear All,
We have a little different perspective for this problem. Vasovagal reactions with TRA normally occur in the beginning of development of a new program. There are four important causes.

1. Multiple punctures to get the radial site access can lead to pain spasm and vasovagal reaction.
2. If you are a new operator you encounter difficulty while working through bad tortuosities and loops. This can lead to excessive instrumentation in that region leading to pain and vasovagal reaction.
3. Intraradial injection of heparin or diltiazem can rarely lead to severe buring sensation and vasovagal reaction because of acidic nature of the solution.
4. If the intervention is significantly prolonged and there are repeated exchanges of guide catheters, while pulling the sheath back rarely there is significant spasm and pain leading to vasovagal reaction.

All these issues are common during first 200-300 cases. Once you overcome these issues the incidence is extremely low. With transfemoral approach the incidence remains the same with the first case and also after several thousand cases.

Take home message:

1.Make sure that most of your radial punctures are first prick.
2.Anticipate and diagnose tortuosities and loops very quickly.
3.Give heparin through intravenous root.
4.Dont be casual in selection of guide catheters and try to complete the procedure in as short time as possible.

 
The standard cocktails for prevention of spasm i.e diltiazem & nitroglycerin cause some degree of bradycardia and decrease of BP. In hemodynamically unstable patients or patients with low blood pressure values e.g. 100mmHg SBP, what drug cocktail is recommended for spasm prevention/how do we address the issue of spasm prevention in such cases? By Monik Mehta, India.

The standard cocktails for prevention of spasm i.e diltiazem & nitroglycerin cause some degree of bradycardia and decrease of BP. In hemodynamically unstable patients or patients with low blood pressure values e.g. 100mmHg SBP, what drug cocktail is recommended for spasm prevention/how do we address the issue of spasm prevention in such cases?
By Monik Mehta, India.

Editorial Board Comments:

Josef Ludwig:

We use only 0.2mg nitro, even in patients with low blood pressure as well as in patients with severe aortic stenosis. Never saw a catastrophe within the last 15 yrs.

Mitchell Krucoff:

We also use this dose of tng, however if the resting bp is less than 100mmHg I routinely accompany with a brisk 500cc bolus of saline as the tng mediated drop in bp is frequently volume related.

Yves Louvard:

We are using 3 mg Verapamil even in acute MI cases. No problem since 15 years.

Jean Francois:

We do use a cocktail of local ia nitro and verapamil without major systemic effect.

Ian C. Gilchrist:

Couple of ideas:

At least in the US we have a calcium channel blocker, nicardipene, that has no effect on the AV or SA nodes. It is approved by the FDA for HTN control. There is literature that shows its affect on the radial and mammary arteries is as good or better than than the other calcium channel blockers without the heart block; also literature to support its use in no-reflow. We use it in 200 microgram doses using that in the radial to start. It also works in coronaries for no-reflow and in higher dosages is an effective IV antihypertensive. I have used it in profound shock directly into the coronary arteries without systemic effects and had resolution of no reflow that reversed the shock state. Use in the radial artery at doses <500 micrograms should not effect the BP.

Local nitrates good be used, but they are very short acting. BP might return quickly but so might the spasm.
Might also raise temperature of cath lab to reduce temperature induced vascular tone. You might be hotter, but the patients vessels will be more dilated.

Tift Mann:

we looked at the hemodynamic response to the radial cocktail several years ago and found a significantly smaller effect of IA verapamil on MAP as opposed to ntg. we thus began using verapamil 3mg alone given immediately after sheath insertion. we have since had no problem with either low BP or bradycardia, including after repeat doses(with are rarely necessary).

Samir Pancholy:

Usually we give 200 mcg of TNG and 5 mg of Diltiazem. If vitals are a problem, we use Diltiazem alone. Its slower onset of action and sustained effect give a good combination of avoidance of abrupt hypotension, and spasm prevention while exchanging.

In STEMI with SBP less than 80 mmhg I give no vasodilator to start, go with the guide catheter based on ECG, and have had no entrapment etc.

Agree with Ian, Cardene is nice, but expensive.

I believe CCB are more important for an average prophylactic cocktail, and nitrates are useful for treating spasm once it has occurred

Sunil Rao:

I've have switched over completely to verapamil 3 mg from NTG based on Tift's data that show a greater increase in radial diameter with little effect on systemic BP compared with NTG. Given the local effects of this low dose I have no concerns about systemic BP.

Olivier Bertrand:

Vera 2.5 mg for us for 15 years.

Tejas Patel & Sanjay Shah:

We follow the following protocol:

1. If the blood pressure is about 100mm Hg then we dont change our regular regimen that is 200mg of NTG + 5mg biltizem intra radial irrespective of status of the coronary and status of ventricular function (normal or abnormal)
2. If the blood pressure is less than 90mm Hg and if the ventricular function is normal then we push the fluids to raise it to 100 or above and then follow the same regimen.
3. If the blood pressure is less than 90mm Hg and if the ventricular function is significantly impaired then we prefer to start vasopressure to raise the BP to 100 or above and if patient has acute MI or severe unstable angina then we deploy IABP and once patient is on IABP we follow the same regimen.

 
A) What are the important points to diagnose true arterial lusoria? B) What is the strategy to enter ascending aorta in this situation? C) What is the incidence of true arterial lusoria in your lab? By Tejas Patel, India

A) What are the important points to diagnose true arterial lusoria? B) What is the strategy to enter ascending aorta in this situation? C) What is the incidence of true arterial lusoria in your lab?
By Tejas Patel, India

Editorial Board Comments:

Josef Ludwig:

I start with C: during the past 15 yrs doing TRA I saw about 5-10 out of 30,000 procedures
B) I try to bend my wire and bring down a Judkind right and exchange via an Amplatz stiff wir. Of not extra back-up caths for left hardly work and we use Judkins left 4, not 3,5.
A) i my wire goes permsnently down to descending aorta I perform a Very often we suspected a lusoria which was not found after angiography

Has anybody tried 5 in 6 with guideliner? Just an idea.

Tift Mann:

Abhaichand et al found the incidence of AL to be 0.3% and this coincides with the experience in our lab. the dx is made with a simple subclavian arteriogram- usually a hand injection is sufficient. the anomaly can usually be traversed with an acute-angled catheter ie JL3.5 and a standard J wire or wholey wire. cannulation of coronaries difficult and it may be best to use alternative access such as left radial.

Olivier F. Bertrand:

Agree with Tift.

There seems to be anatomical variations with AL, i.e. left positionning of subclavian art and aorta....

From our experience in more than 70,000 cases, there have been only a few cases...

One patient came in a few years ago in acute MI and was treated by femoral approach as soon as the physician noted the anomaly. I had to treat a non-culprit lesion a few days later and did it very easily by left radial approach...At that time, I explained to the patient that he had an anatomical variation that explained why I did use the left....He smiled and told me that one of my colleagues had spent about 3 hours in an earlier procedure doing it by right radial...

So as always rule of KISS

Sunil Rao:

Great dialogue!

We have been transradial since 2006 and have yet to see one (although we are a moderate volume lab).

Perhaps it's worth pooling these data together for a worldwide experience paper? If we can find correlates, then one could argue for routine left radial approach in patients with features suggestive of AL.

Yves Louvard:

I have seen myself probably 35-40 of these Lusoria (certainly double for the center including the 11 of initial Abhaichand's paper)
I remember only one failure where the Lusoria was taking off from the proximal descending aorta...
I never spent 3 hours on this problem which can be solved with "shaped catheters, JL ..", an hydrophilic 0.035" wire (Terumo) and then an exchange 0.035" wire. The left radial approach solve the problem of course. And the femoral, but it is forbidden by our religion (patient safety ! ). Collect the cases ? some will be missing after 16 years of radial, but we can try if somebody wants to do it, I can ask to one of our fellows...
The interest is of course to define which catheter is the best ...more interesting will be designing specific catheters for example from virtual reality (from CT san ...) but this is not a market ...I propose the SunilYves catheter !

Ian C. Gilchrist:

I agree with the comments so far. As long as you have a catheter with a shape directional bend, the turn can be made. I have used a pigtail located right at the subclavian/aorta junction and had it point a hydrophilic wire back up the aorta. The Advantage type wire works with a very hydrophilic, low mass leading tip that does not completely over power the catheter shape. The reminder of the catheter transitions into a more substantial wire so as to form the support to make the curve passable as well as not permitting catheters to prolapse down the aorta. Pre-formed Judkin’s catheters delivered directly to the coronaries before removing the angiographic wires has worked well for me.

This is a rare finding so if it does not suit the operator to find a solution, the left wrist is a fine option.

Samir Pancholy:

Great comments. I have had a few cases total, and for some reason, three cases this year that I remember. We have used LIMA catheter to direct the guidewire, and on one occasion each , Tiger and VTK catheter. Once in the ascending aorta, EBU (0.5 size larger.) works well for LCA. For RCA we have used a MAC 4 or AL. LARA curve by medtronic also has a favorable shape that has worked.

A dedicated catheter is a good idea.

Mitchell W Krucoff:

Very interesting to read about cumulative experience, as the entity itself is obviously rare. I have only seen one case, but it was in the first months of my conversion to radial, and i have to admit it took me a while to figure out what was going on. I got the wire around by "walking" a 5 French Tiger over a Wholey wire onto which i placed a steerable "J" tip, advancing the wire, then the catheter, then the wire, etc etc. I could not actually intubate either the RCA or the LCA with the Tiger, and after several exchanges managed to get both with a 5 Fr AL2. I was very glad that this case had normal coronaries, eg that once the diagnostic was complete i did not have go on to a PCI!

my one and only so far...

one additional point that several of our experts have made, not only for AL but in general: IF you are going to abandon the right radial, convert to the left radial, not the femoral!

Tejas Patel & Sanjay Shah:

True arterial lusoria is a difficult but a very interesting anatomy to deal with. In over 31,000 transradial cases we have come across this situation only 43 times (0.13%). All these cases have been well documented angiographically. In the world literature, the incidence mentioned is between 0.2 to 1.7% which seems to be significantly high and difficult to understand. It is possible that, many cases of “Pseudo-arteria lusoria” (significantly dilated and distorted aortic route mimicking arteria lusoria anatomy) must have been included to have the incidence as high as 1.7%.

In first 2000 transradial cases only, we developed a protocol to deal with this situation and it still remains the same with us. The protocol is divided into two parts. (1) Entering the ascending aorta through arteria lusoria and (2) the cannulation of the coronary arteries.

(1) Entering the Ascending Aorta :
Step 1
The catheter and guidewire have a tendency to enter the descending aorta. If this happens, withdraw the catheter and the guidewire together as an assembly.

After asking the patient to take deep breath, gently push the 0.035” standard guidewire. If the guidewire enters the ascending aorta effortlessly, you can then push the catheter over the guidewire.

Step 2
If Step 1 is not successful, keep the guidewire in the descending aorta. Remove the Judkins right or left catheter, or the first catheter you tried. Take a LIMA diagnostic catheter, put it into the descending aorta over the guidewire, and try the same maneuver. In many cases, you will be successful in entering the ascending aorta.

Step 3
If the LIMA catheter fails, then a Simmon catheter can be used to enter the ascending aorta.

Step 4
If the 0.035” standard guidewire has a tendency to slip into the descending aorta, the second choice is a 0.032” or a 0.025” hydrophilic Terumo Glidewire. The slippery Terumo wire facilitates relatively easy entry into the ascending aorta in challenging situations.

Note :
• Always work in the 40-degree LAO view.
• Do not use super-stiff guidewires unless you have entered the ascending aorta.

(2) Cannulation of the Coronary Arteries :
Once the guidewire and the catheter are in the ascending aorta, cannulate the left or right coronaries in the usual fashion.

It is relatively easy to cannulate the coronaries. If there is a challenge, follow these steps :

Step 1
Remove the standard 0.035” guidewire or the Terumo Glidewire, whichever you used first.

Step 2
Using a 0.035” super-stiff guidewire, make a loop of wire in the ascending aorta, and slowly negotiate the catheter over it so that you can make a loop of the assembly (catheter and guidewire).

Step 3
Slowly pull the guidewire slightly inside the mouth of the catheter and pull the assembly back. This usually cannulates the left coronary artery.

For cannulation of the right coronary artery, slowly and gently rotate the assembly clockwise.

For diagnostic procedures, use a Judkins left, Optitorque TIG, or an Amplatz left catheter to cannulate the left coronary ostium. Use a Judkins right or an Amplatz left catheter to cannulate the right coronary ostium.

For intervention in he left coronary arteries, choose any extra back-up guiding catheter as your first choice. If this is not successful, use a Judkins left or an Amplatz left guiding catheter.

For intervention in the right coronary arteries, Amplatz right is the first choice. If this does not succeed, a Judkins right or an Amplatz left catheter can be used.

Note :
At any stage during cannulation of the coronary ostium, do not push too much or the assembly may flip into the descending aorta.

These steps may seem complicated, but arteria lusoria is very rare, and patience and perseverance can help you complete the procedure in the usual fashion. If the first few attempts to enter the ascending aorta are unsuccessful, gracefully switch to the left radial or to the femoral route. Once you beat the learning curve, it is possible to work through this anatomy in practically hundred percent cases.

It is a great idea to pull the data from all of us to publish a combined experience.

Kintur Sanghvi:

It is clear that all of us want to have a very fruitful conclusion from this discussion. If we can come up with data to guide current and future radialist on how to deal with AL, it will help forward our “Radial” religion and reduce complications for our patients.

All though opinions in this discussion are coming from the world’s best and most experienced radial operators, some of the opinions are differing from each other.

 
In France nephrologists seem to prefer radial rather than femoral access in pre transplant patients, as femoro-ilac damage appears to be greater risk for transplant adoption rather than the risk of loosing a shunt artery. We until yet saw radial access as contra indication in patients suffering from renal impairment. What do the world´s expert think? By Josef Ludwig, Germany.

In France nephrologists seem to prefer radial rather than femoral access in pre transplant patients, as femoro-ilac damage appears to be greater risk for transplant adoption rather than the risk of loosing a shunt artery. We until yet saw radial access as contra indication in patients suffering from renal impairment. What do the world´s expert think?
By Josef Ludwig, Germany.

Editorial Board Comments:

Samir Pancholy:

I agree. The risk of embolization to the renal graft by femoral route logically would be expected to be higher than radial access. With low profile equipment and patent hemostasis etc, the risk of sacrificing the radial by accessing it is small and clearly worth avoiding the risk of instrumentation around the renal graft pedicle.

Ian C. Gilchrist:

I would second the other remarks. Since pre-transplant procedures tend to be only diagnostic I use 4 French catheters and minimize the trauma to the radial. We also have an active liver transplant service and radial is very good for these patients as they often have low platelet counts and elevated clotting times that are not easily corrected for femoral access.

Tak Kwan:

1. Agree with Sam and Ian's comments.

2. If the radial occlusion rate is acceptable, should it be not a relative contradiction in pts with AV fistula on hemodialysis?

Sunil Rao:

Excellent discussion so far.

At TCT last year, there were 2 abstracts from Europe looking at the transradial diagnostic and PCI in patients who had AV fistulae in the ipsilateral arm. All procedures were successful and there were no reports of graft loss. It's not a randomized trial, but chances are that such a trial would be difficult to do.

Regarding the question from Professor Ludwig, I think that radial should be the preferred route for all of the reasons outlined thus far.

Jean Francois:

Interesting question and historically would have gone with the femoral route but now with smaller catheter do not believe it is a contraindication to go from radial. Actually agree could be the most favorable route!

Yves Louvard:

True Josef !
Our nephrologists ask us to perform angio and PCI from radial approach.
The risk of hemorrhage with Femoral approach is high.
The occlusion rate after radial approach can be reduced to less than 1% with patent artery compression, and there is no serious data about any problem with creation of a fistula (like for radial and graft ...).

Kintur Sanghvi:

First I wanted to discuss briefly some basic information about the AV grafts, which may help some of the readers.

An arteriovenous (AV) fistula for hemodialysis can be created using native (primary or autogenous) vessels: For long-term dialysis, a native or autogenous AV fistula has the longest patency rates among the access options, lowest rates of local or systemic infection, lower rates of thrombosis and the delivered dialysis dose is superior to tunneled cuffed dual lumen catheters and comparable with grafts. These fistulae are typically fashioned to connect the radial artery to the cephalic vein, the brachial artery to the cephalic vein, or the brachial artery to a basilic vein.

A synthetic bridge conduit, typically a polytetrafluoroethylene (PTFE) graft: The preponderance of hemodialysis access in the US consists of synthetic AV fistulae, primarily PTFE grafts. The reasons for this practice (of course we like it all easy) include the following: bridge grafts are technically easier to create and manipulate than native fistulae, lower initial nonfunction rates and the grafts can be used earlier postoperatively compared with native fistulae, which require 1–4 months to mature

There are few published reports of using radial access safely and successfully for endovascular intervention of the AV grafts/shunts to treat a stenotic or occluded dialysis access or to expand the shunts that failed to mature. (Reference: Nephrol Dial Transplant. 2009 Aug;24(8):2497-502. Epub 2009 Mar 3). I have used radial for the similar procedure twice with success. Dr Smiraldy, a vascular surgeon in Scranton primarily uses radial approach for all dialysis access interventions.

With this information, I think it is very reasonable to prefer radial access with up to 5 Fr catheters to perform pre-transplant left heart catheterization in a patient who has upper arm dialysis access. Particularly it would be safer then manipulating through the generously populated calcified ahteromatous plaques in the aortoiliac system of ESRD patients who have a kidney transplanted to iliac system.

Josef Ludwig:

Thanks for your responses. TIME to do a study and time to come to a consensus.

The experts of transradialWORLD, have the chance and obligation to rule out guidelines.

Never understood why there is European bifurcation club and Japanese CTO club. But, no world radial club to gain importance and recognition.

Kintur Sanghvi:

Absolutely agree with you.
I will discuss with our website staff and may be we can all contribute to a central database/ protocol related to this particular issue and come up with a fast conclusion. I hope this idea is not over ambitious.

Tejas Patel:

I completely agree with all of you that there should not be any issue about working through radial route in this sub set of patients. However in India most nephrologists would discourage us for the usage of radial artery for the reasons best known to them.

 
How easy is it to upsize a radial sheath from 5F or 6F to 7F if the patient is going to need roto or ULM PCI? What percent of patients are able to take a 7F sheath, and is there some way of evaluating this before the procedure? Are there dedicated 7F long lubricious sheaths for TRI on the market? By Nitin Chitale, US

1. How easy is it to upsize a radial sheath from 5F or 6F to 7F if the patient is going to need roto or ULM PCI?
2. What percent of patients are able to take a 7F sheath, and is there some way of evaluating this before the procedure?
3. Are there dedicated 7F long lubricious sheaths for TRI on the market?

By Nitin Chitale, US

Editorial Board Comments:

Josef Ludwig:

Do not see the problem of upsizing. Works like fem. We work with 6 F in men also for diagnostic and perform ad hkc procedures, thus, upsizing is rare. In woman with 5 F. We inject 0.4 mg nitro before changing. IF you use Terumo pediatric sheath a standard 0.34 wire not works. You have to take 6F Terumo fem sheath or a 0.22 wire. 7 F question has been answered extensively last week.

Ian C. Gilchrist:

Up sizing is a trivial exercise. I use a .035 inch wire to exchange all my angiographic catheters. If I need to up size between a catheter exchange I pull the initial radial sheath (usually a micropuncture kit’s device), remember to hold pressure at the entry site when the sheath is absent, and insert a sheath whose dilator will pass over the .035 inch wire (ie femoral type sheath system). You then remove the dilator and pass up your next larger catheter without ever loosing central wire access. I do this with a standard 180 cm wire (jetting catheters), but if you like long wires the process is the same. No need to downsize to a .021 or smaller to get a micropuncture sheath in once you have access.

As far as 7F sheaths, I have not used one in years despite 95% radial. Five French is a great way to do procedures once you are comfortable with the technique (advanced technique). If you routinely use 5F, then 6F is more than large enough for special projects.

Hydrophilic sheaths have advantages, but there was a recent study that showed that the length of the sheath was not associated with benefit. I would stay short to minimize bulk in the artery.

I am sure there are multiple opinions on this point.

Mitchell W. Krucoff:

I largely agree with ian.

I am less comfortable with 5Fr guides routinely, esp multi-wire cases.

His description of upsizing sheath etc without losing control of central access is excellent. Once the smaller sheath is out, I just go with the whole new sheath and dilator together in a single step.

I have never used a 7fr system from the radial. Other than triple-kiss balloon or rotoblator larger than 1.5, I haven't used a 7 fr guide from the arm or leg in many years.

I also agree with ian: I prefer hydrophilic sheaths, and shorter over longer sheaths. Only exception for latter might be a perforation scenario where the sheath is used to cover the perf site.

Ian C. Gilchrist:

That is a good point Mitch made. A long sheath when a radial perforation is suspected makes sense.

Josef Ludwig:

Since we use a special puncture technique radial artery perporation or dissection has vanished. At first glance this technique may look cumbersome, but, once Ou do it more often, you fast and safe. For those who are interested it was recently published-July 2010- in Eurointervention.

When I started radial in 1995, I had a good friend who already died and he was a world recognized pediatric interventionist. He told me that cath in premature patients via fem causes severe spasm and recommended the Terumo pediazric sheath. From then on we stick to this sheath. Thats why I mentioned this device.

Samir Pancholy:

Agree with you folks. Never have had a need to use 7 F. arm or groin.

One technical issue when upsizing from 5F to 6F over 0.035" 260 wire is you will need a regular 6F pinnacle sheath dilator put in the glidesheath 6 F introducer sheath, as the radiofocus glidesheath dilator is a 0.021" capable lumen all throughout its length. We stock separately packed 6F dilators in our lab for this purpose.

Tejas Patel:

I agree with Ian & Mitch. For the exchange of sheath we use the exchange length wires.Nothing much to say. As of now I had no opportunity to use 7F introducer sheath. However if I am compelled to use it I will do a radial angiogram and if I find the radial artery size good enough for 7F sheath without hesitation I will use it.

Yves Louvard:

1. If you are using a 0.035 wire you can insert a femoral sheath without any problem after removal of a 5F ...If you use a 0.025 wire take a     bigger radial sheath: VERY easy

2. In a study I made, IN France (males and females), a long time ago, the % of radial arteries (after nitrates) accepting:
    5F = 100 %
    6F = 86.9 %
    7F = 76.9 %
    8F = 64.7 %
    Mean radial artery diameter: 2.9 +- 0.6 mm

3. Terumo have long sheathes ( 20 cms ?), they are not VERY lubricious But why using 7F for Rota ?, for ULM ? A 1.75 mm burr is 6F     compatible, most left main stenting techniques (excepted SKS) are 6F compatible ...

But why using long sheathes ? A 6F sheath is in fact 8F in diameter which is acceptable on 7 cms, but sometimes not on 20 or more cms ! So for 7F approach (9F diameter...)!

 
While transradial techniques make same day discharge after PCI feasible, what percent of your elective cath/PCI patients do you discharge same day? By Ian C. Gilchrist, USA.

While transradial techniques make same day discharge after PCI feasible, what percent of your elective cath/PCI patients do you discharge same day?
By Ian C. Gilchrist, USA.

Editorial Board Comments:

Sunil Rao:

We have a protocol for same day discharge but only a minority of our patients qualify due to the distance they travel. Our current proportion of same day discharge is < 5%.

Mitchell W. Krucoff:

Important to remember that same day discharge is about more than just the vascular access site.

Safety is first and foremost dependent on the coronary anatomy and intervention itself, including both the quality of the PCI result and the transition to optimal adjunctive medical regimen.

In the USA, hospital administrators may also be sensitive to the fact that reimbursement levels may drop for same day compared to overnight stay. So if TRI is directly associated with increase in same day PCI, it may be perceived as dropping hospital revenues.

So rather than having TRI become leverage for more smae day PCI, may be preferable to recognize that TRI is better for vascular access in all PCI, same day or not.

Jean-Francois Tanguay:

Good question...as our 'elective PCI' population is much smaller but pending several variables such as age, time of the day and how far the patient comes from, we send 15-25% of our low risk elective case home the same day.
We started several years ago with a nursing follow-up program to assess safety and feasibility.

Sanjay Shah:

Same day discharge is not advisable for cardiac safety reasons (arrhythmias , subacute thrombosis are not related to vascular access).

David Hilton:

I attached our paper from 4 years ago. This followed a publication of elective same day discharge in the 90s , all radial. We have sent >70% home for many years. The reason it is not done in many jurisdictions is because the payer won't pay for same day so the real question is not how many actually go home but rather how many could .

View Paper


Same_Day_Discharge_
Radial_PCI_._Smal

Kintur Sanghvi:

In agreement with Mitchell’s comments, we discharged a couple of transradial Renal artery interventions on the same day and the Hospital was sensitive about the same-day discharge. Patients are sent home the same day after IVUS or FFR via radial but no PTCA or stenting; however, I may or may not discharge the patient if the same procedure was done through femoral.

We need an effort by the interventional community and hospitals to change the scenario of the reimbursement for patients being discharged the same day. Ultimately the advantage of the cost saving with radial approach should translate to health care dollars saved, with patients being discharged the same day, particularly for the uncomplicated peripheral PCIs and Type A or type B elective coronary interventions done via radial. These procedures are a great portion of procedures done in US cath labs.

Tak Kwan:

Dear all,
Agree with Kintur.
I routinely discharge simple PCI patients (type A) home same day via transradial, if we did the case before 2 pm. I don't think I will do the same transfemorally. Reimbursement is the major problem as we all agreed. Safety is not concern if we select low risk patients and monitor patient for 6 hr. Recently, we wrote an Editorial about it in July issue of Journal Invasive of Cardiology.

Tejas Patel & Sanjay Shah:

We have done a pilot study of outpatient PCI by not discharging the patients from the hospital but sending them to the rooms rather than ICCU.
100 such patients were kept in the rooms without cardiac monitor and they were given telephone numbers of ICCU as well as doctors on duty. It worked out very well without any major issues. However till this date except for very few cases we have not started discharging the PCI patients on the same day.

Josef Ludwig:

In Germany presently PCI patients stay overnight. Mere angiography patients can leave after 6 hours usually. However, we keep them all overnight. It is a matter of in-hospital administration matters.

Samir Pancholy:

I have sent very few PCI patients home the same day, but I think this will soon change especially when guidelines become more inclusive and bundled payment etc encourages it I certainly believe that TRI patients are much better suited for same day discharge compared to TFI patients.

 
Does exist any way to determine clinically the diameter of radial artery to know if we can use safely a 6F or 7F catheter? By Victor Alfaro, Cook Island.

Does exist any way to determine clinically the diameter of radial artery to know if we can use safely a 6F or 7F catheter?
Victor Alfaro, Cook Island.

Editorial Board Comments:

Josef Ludwig:

No need to check, in kauasians 6 French works in 99 percent of male and 5 in women. 7 French is suitable for terrorists.

Next generation experts will work with 4F guides and 2F diagnostic (Japanese slender club) I am sure.

Ian C. Gilchrist:

I think you get a sense of the vessel diameter by palpation and experience. The need for 7F is almost never in my experience. I use 5F as standard PCI and 6F for special occasions. 4F for diagnostic in the USA. While smaller guides have a different feel than larger guides, they are usually just as successful. If you truly need a large bore catheter, then you may need to use the groin.

Tift Mann:

One ca assess radial diameter with doppler after sl ntg but I am not aware of any radialiat that uses the technique. We never use 7F even with carotid stenting. Further, with the increasing concerns about radial artery injury and occlusion, 5F is our default strategy and we use 6F only for complex cases.

Tak Kwan:

All diagnostic is 5 F; Most PCI is 5F and 6F for complex cases. 7F is unusual and only in big radial artery in man (by palpation) and no need for Doppler.

Tejas Patel:

Clinically there is no precise way to assess the diameter of radial artery. More than 95% of the radials will easily accept 6F sheath. In muscular or athletic people with big wrist even 7F sheath can easily be introduced. I agree with Dr. Tift Mann about the role of vascular Doppler to measure the radial artery diameter. However it is not practical in all the cases.

 
As a single diagnostic/interventional catheter/LV cath/injection catheter what are my options in the United States. Is there a "Tiger" equivalent in 5 0r 6 F that can be used for all the purposes listed above as a SINGLE go to catheter for most cases. Our company options would be mostly Medtronic, Terumo and Boston Scientific. What do readers generally do? Also as a routine strategy of left radial access/right side of table operator position with the left arm brought across the body (or next to it) for access from the right side of the table, are there relative pitfalls compared to the more usual routine right radial/right side of table access (leaving aside the LIMA access and graft access issues).

As a single diagnostic/interventional catheter/LV cath/injection catheter what are my options in the United States. Is there a "Tiger" equivalent in 5 0r 6 F that can be used for all the purposes listed above as a SINGLE go to catheter for most cases. Our company options would be mostly Medtronic, Terumo and Boston Scientific. What do readers generally do? Also as a routine strategy of left radial access/right side of table operator position with the left arm brought across the body (or next to it) for access from the right side of the table, are there relative pitfalls compared to the more usual routine right radial/right side of table access (leaving aside the LIMA access and graft access issues).

Editorial Board Comments:

Josef Ludwig:

I not familiar with Tiger. Sorry. I do left with JL 3.5 or Ludwig left by Cordis. The RCA I do with MP and also LV by Hand injection. Or More frequebtly use JR for LV and RCA. But, You need good flat panel immage quality. N.B. Prefer now JR and JL. Despite there is Ludwig left available. Sorry for my own cath.

Kintur Sanghvi:

A single diagnostic catheter for left, right and LV (available in 5 Fr):

Tiger (Tremor) Jackie (Terumo) and Sarah (same shape as Jackie with a little bigger secondary curve) are available in US market. (we have them in our lab).

We routinely do LV angiogram with hand injection with one of this catheter. It is adequate in most of the cases.

Crossing Aortic valve with JR catheter is easiest from right radial followed by Jackie. If you are switching from fem to rad, JR4 and JL3.5 are better choice to start with.

A single Guide catheter for left, right and LV:

Tiger guide is available in 6 Fr size (we have it in our lab, and I start STEMI case with it)

I do not know if PaPa Guide is commercially available? We have it in our lab in 5 fr size. Patel Pancholy (PaPa) curve (Medtronic) is the other single guide for LV, Left and Rt coronary. I have little difficulty using that guide for left, but in my opinion its probably the best curve for RCA from right radial.

Samir Pancholy:

In the US a 5F Tiger and Jackie diagjostic catheters are available. Tiger guide is not available yet. Your choices for universal guide in US are Kimny, PAPA or PAPA1, and in some instances MAC ( which is the old Patel curve). These are guides especially PAPA, PAPA1 and MAC are available in 5 and 6F.

Sunil V. Rao:

The Tiger, Jacky, and Sarah diagnostic catheters are available in the US from Terumo. One can also use a Multipurpose A2 or B2 as a single catheter strategy. There are two studies that have been presented but not yet published suggesting that a routine left radial approach may shorten procedure times in patients who are older than 75 years and shorter than 5'5", potentially due to less tortuosity of the subclavian artery.

Mitchell W Krucoff:

Dr's. Rao and Pancholi have summarized nicely.

Both 5 Fr and 6 Fr Tiger diagnostic catheters are available, from Terumo, in the USA, but guide shapes are only in 6 Fr so far, and even with "power" position have limited backup. the one very nice aspect of the Terumo 6 Fr outer surface is its lubriticity--we have used it even when there was a good bit of spasm around a 5 Fr diagnostic, and yet this 6 Fr guide went easily.

For diagnostic I use the Tiger as first choice at this time, 5 Fr in women and 6 Fr in most men. using this one catheter also helps me get a better feel for what to do next if there is a takeoff I cannot cannulate--eg whether to go to a judkins, amplatz or multipurpose.

Hildick-Smith David:

My suggestion to you is, don’t bother.

A “one-catheter” approach only works in 80% of cases.

Its fun, but its not really clinically useful to try with one catheter, it will inevitably not be quite right for either LCA or RCA in a proportion of cases.

JL3.5, JR4, Pig.

Josef Ludwig:

I completely agree with Dave. Do not make things even more simple! (A. Einstein)

Tejas Patel:

A "Tiger" equivalent catheter in 5 or 6 F which can be used left and right diagnostic catheterisation as well as intervention is a dream situation. But the dreams do not always come true. It is important to understand that Tiger is a reasonably good catheter for diagnostic coronary procedure. However it is a weak 'backup' curve for intervention. There is another drawback of Tiger catheter is the tip faces towards LMCA roof leading to difficult coaxial alignment. We are trying to develop PAPA and PAPA1 curves (Medtronic) to overcome the drawbacks of Tiger and after further refinement I am sure that these curves will be reasonably good for left and right interventions. Repeated changes of diagnostic or guide catheters can lead to radial artery spasm but if done carefully a couple of exchanges are alright. Up to an extent I agree with Dave.

Josef Ludwig:

Indeed 1 cath strategy is not meaningful, but, the solution was done decades ago by Sones. U only need it longer as from brachial and is time consuming even in expert hands. 2 caths and less radiation dose is best in my opinion.

Yves Louvard

I have sustained and published a long time ago the "look for the perfect multipurpose catheter" with multipurpose Sones, AL2, 3D (my catheter lost with Bard, it was good, JL, tiger ... Today after at least 15.000 transradial angiographies, I am using ...JL, JR ...like Josef ...sometimes, only to remember good old times and in absence of fellows I use AL2.

The reasons:

- frictions are not always spasm and the diameter matters more that one or several catheters and shapes ...
- spasm is very rare today as we are working quickly on well prepared patients in a quiet and a highly successful ambiance (important for next   patients) and have specific techniques for catheter exchange.
- it is not increasing procedural and X Ray times

It does mean that we won't have next year the ideal catheter.

 
During transradial diagnostic coronary angio many a time optitor 5fr gets deep into RCA when I try to hook RCA Ostium. It scare me of dissection/spam/dye hanging. How to improve on this? To my experience this is less observed in JR Catheter. Ramchandra Barik, India

During transradial diagnostic coronary angio many a time optitor 5fr gets deep into RCA when I try to hook RCA Ostium. It scare me of dissection/spam/dye hanging. How to improve on this? To my experience this is less observed in JR Catheter.
Ramchandra Barik, India

Editorial Board Comments:

Josef Ludwig:

I have no experience at with this type of cath. For 15 yrs wd use JR or MP for diagnostic as first choice. In certain circumstances AL 1 or 2. The modern soft tip cath rarely cause disection, and, of note before the 5 in 6 device came to market 5 F deep intubation was an ellegant tool for better support in difficukt PCI cases. In summery do not be too afraid.

Sunil V. Rao:

The Tiger catheter can occasionally dive deeply into the RCA. The way to avoid this is to torque it clockwise and not pull back or only pull back minimally so it sits oblique to the RCA ostium. Since the catheter has a sidehole, placing it oblique to the RCA ostium will allow good filling of the artery without a risk for dissection. It does take some practice.

Ian C. Gilchrist:

I am not familiar with that curve, but as mentioned by Dr. Ludwig, the smaller sized catheters are far more benign than the history of dissection established by the stiffer 8 F systems that are referenced in the literature. My suggestion to our trainees is not to encourage deep intubation, but if it occurs the first reaction should be to relax and the doctor take a deep breath. If the pressure waveform is okay and the tip appears co-axial in the vessel use it for angiography. To reflex and pull the catheter out may set you up for once more deep intubation with the next attempt. It is the moment of uncontrolled entry into the coronary that poises the greatest risk (although with small diameter, flexible tips this risk is very small) and if you have already passed that point, you should take advantage of it assuming the tip is in a reasonable lumen location.

To avoid deep intubation a second time, I have noted that if you enter the RCA from the opposite direction from how you deeply intubated it often controls the entry better.

Tak Kwan:

I have a large experience in using the Optitorque catheter which either a Tiger or Jacky Catheter. Similar to any catheter, if not careful in engagement, dissection/spasm will occur. In engaging the RCA, I usually slowly turn clockwise and keep the catheter downward, of course pay extra attention to avoid the sudden "deep throat". It should not take a long learning curve to do it.

Samir Pancholy:

In our experience, Tiger catheter is very safe from a dissection risk standpoint. It tends to frequently engage the conus and needs to be "straightened out " with the stiff end of the J wire to access the right. It tends to deeply engage RCA but if coaxial there is no problem. In fact the Tiger guide is a very good RCA guide for this reason .

Tiger diagnostic could also be used non-coaxially to opacify the coronary as it has a tip side hole.

Josef Ludwig:

A good idea which I learned from Dr Louvard for deep intubation for better PCI support of RCA was clockwise rotating down the RCA. Thus, backwards if your diagnostic runs down deeply, consequently should be counterclockwise pull back Never did, but seems logical

Tejas Patel:

I agree that right JR catheter does not dive deeply while cannulating RCA. However while using 5F TIG catheter (Terumo) one has to be careful for 2 problems

1. Sometimes it may dive deep into RCA and can damage the ostium or create a dissection.

2. It has a tendency to selectively hook the conal artery and if the catheter is not removed timely the contrast hold-up can lead to ventricular     fibrillation.

The answer for the 1st issue is while cannulating RCA the TIG catheter tip should be kept very much on the aortic valve and very slow clockwise rotation should be done. Sometimes even with this manoeuvre the catheter tip moves much faster than expected and in that case a slow clockwise rotation should be combined with a little bit of counter clockwise rotation. Thus clock-counter clock movement done slowly will give you a better control of the tip movement and will eliminate chance of ostial injury or dissection or deep diving. The answer for the problem 2 is when you know that you have cannulated conal artery and there is hang up of contrast, you immediately remove the catheter and again try to hook the RCA. If by chance it again cannulates the conal it is being identified by damping of the pressure tracing. Don’t inject the contrast and use the opposite end (stiff end) of 0.032" Standard guidewire and push it carefully up to the primary curve of the catheter. It will open up the curve and successfully cannulate the RCA ostium.

This is a genuine real world issue and beginners must know the troubleshooting.

Mitchell W Krucoff:

There have been many very excellent comments on this, so i can add only a little:

1. No question that there is a trade-off between universal catheters like the TIG vs. using JR/JL catheters. in favor of the JR/JL includes the less     aggressive tendencies toward conus and deep cannulation of RCA body than we see with the TIG. However this approach also uses more     catheter exchanges, may promote more radial spasm, etc. Learning to control the TIG removes these extra steps, and is the approach that I     favor in my personal practice.

2. We frequently put in 6 Fr sheath, and in male patients i tend to use 6 Fr TIG, rather than 5 Fr, which to my touch has more direct control.

3. I think Tejas's description of very controlled torque (clock but then counter, to control the speed of tip movement and buildup of torque)     keeping the TIG deep in the cusp is exquisite and critical.

4. When this approach still finds only the conus, i do find there are times when slightly increasing the amount of pullback i apply while torquing     can "flatten" the tip or "verticalize" the catheter, allowing me to rotate into the RCA ostium rather than the conus--this is very similar to what     is done with the stiff end of the wire, but using limited pullback rather than the stiff end of the wire.

Finally, least importantly perhaps, is that this upward reach of the TIG that must be managed to avoid the conus is actually quite nice for non-dominant rights with high takeoffs!

Great dialogue all!

Kintur Sanghvi:

Straightening of the secondary curve to some extent by pulling on the catheter with the index finger and the thumb while fixing the catheter between the palm and ring finger (like we straighten the J wire) helps take the tip of the TIger out of the Conus and it will advance in to RCA. Like Sam said, 6Fr Tiger catheter may be a good guide for Inferior STEMIs. For using 6Fr Tiger guide, one is better off following all the care Dr Patel described.

The "Jackie" and "Sarah" catheter (Terumo) the tip is very flimsy, atraumatic but at the same time not as stable on torque. Even 10-20 degree torque at times can move the tip from left to right coronary cusp. This shape is better than TIger to cross the AV and perform LV angio. "Sarah" tends to go in to LCX selectively, but essentially atraumatic tip. I have used it once to my advantage to perform FFR of intermediate lesion through very torutous LM/LCX anatomy.

For someone switching from Femoral to Radial, I feel it is better to start with JL3.5, JR4. The second choice would be TIger. Jackie shape requires real fine movements, that shall be the last choice.

 
What measures can reduce the radial occlusion? What is the radial artery occlusion rate using those measures? Eliezer Hernandeze, US.

What measures can reduce the radial occlusion? What is the radial artery occlusion rate using those measures?
Eliezer Hernandeze, US.

Editorial Board Comments:

M. W. Krucoff:

This is a really key question that affects our patients, our practice and this whole field.

samir should probably jump in, as best work available is their "patent hemostasis" experience, which we consider to be the standard at this time. our approach uses the TRI band and a pulse oximeter with continuous waveform display on finger of the intervention hand. we attach the TRI velcro band so that it is firm but not too tight, then inflate with 15 cc air. we then slowly deflate until there is visible bleeding, easy to see through the transparent TRI band. we then add back 3 cc of air, so the bleeding stops.

the next steps are the key: with the TRI band inflated to hemostasis, we compress the ulnar artery and watch the pulse ox waveform. if it is flat line, we deflate one cc of air and test again. we continue this process until we have visible hemostasis, but also some pulse ox evidence of flow when the ulnar is compressed.

one trick in compressing the ulnar: find an ulnar position that does not actually require you to touch the TRI band. if you put pressure on the TRI band while compressing the ulnar, your assessment of radial flow can be distorted.

there are some patients where you simply cannot find both hemostasis and radial flow. as samir can detail, these sites are high risk for long term occlusion.

finally, what are the real rates of radial occlusion, with how many repeat procedures, and over what period of time is not well reported. these data should be considered a very high priority for the radialist community to responsibly gather and report.

Samir Pancholy:

I totally concur with Mitch's comments.

Besides heparin , and lowest pissible profile hardware, patent hemostasis is a must. He has described the technique very well.

We have observed RAO rates to be very subset dependent. In diabetic females you will probably see the most occlusions and in large men probably the least. When heparin is used and especially patent hemostasis is used these variables loose their statistical significance as predictors of RAO, but there is still a trend towards their association.

In our latest observation RAO, plethysmography/ultrasound documented, occurs in 2-3% of patients after 5 or 6 F access.

We are investigating a few other strategies to further lower this number.

Yves Louvard:

For me 3 major concerns:

- Avoid stressing the radial artery diameter (mean diameter in a French series 2.9 mm ID): downsizing, sheathless.

- Heparin: never less than 5000 U for a midsized patient (adapt?) for a coronary angiography, ACT > 300 sec for PCI.

- Controlled short compression: short flow occlusion (20 minutes?) and then 2 hours compression with antegrade flow (doppler, plethysmo, oxymetry ...).

With this the occlusion rate is < 1% (See Monsegu J on Pubmed medline).

1. Vascular approaches and closure devices for percutaneous coronary intervention. Monsegu J, Karrillon GJ, Schiano P, Ouadhour A. Ann     Cardiol Angeiol (Paris). 2007 Dec;56(6):263-8
2. EuroIntervention. 2010 Jun;6(2):247-50. doi: 10.4244/.Adjusted weight anticoagulation for radial approach in elective coronarography: the     AWARE coronarography study. Schiano P, Barbou F, Chenilleau MC, Louembe J, Monsegu J.
3. Radial artery compression techniques. Monsegu J, Schiano P. Indian Heart J. 2008 Jan-Feb;60(1 Suppl A):A80-2. Review.
4. Interruption of blood flow during compression and radial artery occlusion after transradial catheterization. Sanmartin M, Gomez M, Rumoroso     JR, Sadaba M, Martinez M, Baz JA, Iniguez A. Catheter Cardiovasc Interv. 2007 Aug 1;70(2):185-9.
5. Left radial approach for coronary angiography: results of a prospective study. Spaulding C, Lefèvre T, Funck F, Thébault B, Chauveau M, Ben     Hamda K, Chalet Y, Monségu H, Tsocanakis O, Py A, Guillard N, Weber S. Cathet Cardiovasc Diagn. 1996 Dec;39(4):365-70.

Sunil V. Rao:

Agree.

The 3 key concepts are
a) minimize trauma (avoid spasm, large catheters in small arteries);
b) anticoagulation;
c) patent hemostasis.

With this, radial occlusion can be minimized. It likely will not be eliminated, so more research is needed in this area.

Josef Ludwig:

Completely agree this time with Yves and, above, very much hope the ideas of Japanese slender club
will come available outside Japan. 2F diagnostic and 4F for PCI.

And maybe its time to think for closure devices such as thrombin subcutaneously or fibrin plaster or modified Exoseal for radial.

Tejas Patel:

I learned the measures to reduce radial occlusion from the great work of Samir. We started following it and have been able to reduce radial occlusion rate from 5% to 2%. Samir should describe his method at length and I think it should be useful to all the viewers.

 
Which diagnostic catheter you will advise for searching lima graft in trans radial route?Ramchandra Barik, India

Which diagnostic catheter you will advise for searching lima graft in trans radial route?
Ramchandra Barik, India

Editorial Board Comments:

Josef Ludwig:

IMA for LIMA. We use only left radial as we are not so acrobatic like Yves and others. My success rate is only 60 percent or less, and, in case of r failure we jeopardize both radials. For our comfort we introduce a 25 cm arroflex and thus work like right femoral.

Ps the arroflex only ca 5cm in the radial.

My left radial LIMA approach:

Tift Mann:

Ima or mann ima guide(boston) via left radial and TIG via right radial (rarely).

Ian C. Gilchrist:

Several options to consider. In general, I am presently using the IMA curve although at times the JR4 will work. In the past I have also used RLIMA’s with modest success.

The easiest approach is the ipsilateral radial, so if you have a LIMA graft, start your procedure with the left radial. Gaining access to the ipsilateral IMA is far easier from the radial than from the femoral as you are already in the subclavian artery.

The challenge is the contralateral IMA. I usually warn the patients with bilateral mammaries that I might have to use both radials to finish the case. Most patients gladly accept this over being stuck in the groin. If there are bilateral IMA’s, I usually start in the right radial as the right subclavian is often more difficult to pass up retrograde than the left. Typically the right IMA will be easily found and imaged. One then needs to get the left IMA.

The key to the left is getting a wire into and down the left subclavian. Most recently I have been using an approach with the IMA catheter resting on the inner curve of the transverse aorta and using it to point a wire up into the left subclavian. With the IMA catheter’s hooked curve, movement in or out adjusts the longitudinal position of the aim will twisting the catheter slightly changes the radial direction in the aorta so the left subclavian origin can be found. I have used standard .035 J-wires and hydrophilic wires successfully. More recently I have used an Advantage wire by Terumo that is a hybrid between the classic hydrophilic wire and a stiffer shaft of a regular wire – this allows entry into the subclavian and the a rail to slide the catheter. Regardless of the wire used, the key is to pass the wire deep down the left arm arterial tree (brachial artery). With the wire firmly placed into the distal arterial tree, you can then slide the IMA catheter from the transverse aorta up into the left subclavian and then distal to the takeoff of the LIMA. Remove the wire and then flush the catheter. Slowly then pull the catheter back towards the proximal subclavian to engage the LIMA.

Good luck.

Josef Ludwig:

It is worth to try a JL to get from r to l, and use the J stiff hydrophilix Terumo down to the cubital part and have your cimpress the cubital.

Yves Louvard:

From Left radial a mammary catheter or a modified mammary catheter (Tift Mann)
From right radial a mammary 5F catheter (special technique) ou a Yumko (available in Japan only

Mitchell W. Krucoff:

Many excellent answers already written.

I am still an "ipsilateral" guy, although with surgeons taking the left radial this will be problem for the LIMA some day.

I like the universal catheters, in particular Tiger. From the left radial, the long tip of the Tiger can frequently intubate or at least adequately opacify the LIMA. Then over the wire we try to get left and right coronary and SVGs also with the Tiger. If we need another catheter at all it is usually a multipurpose for a posterior SVG takeoff. But overall this minimizes case time and catheter exchanges.

Hildick-Smith, David:

I think we need a new catheter for this.

I find that the LIMA only goes in from the LRA in 70% of cases and the remainder need an angioplasty wire to facilitate entry as the “hook-back” is too great.

A catheter with a shorter length but sharper hook is required. Perhaps Tift Mann’s catheter does this but I have not had access to it….

Tak Kwan:

I always approach the LIMA from the left radial artery (if the surgeon did not take it out). My catheter of choice is IMA catheter then JR4. I agree with David that the selective cannulation is around 70% and may need a coronary guidewire to cannulate it selectively. We always perform it from the patient's right hand side.

 
What are the different way to achieve hemostasis after radial procedure? Is one superior to another?Stamatis Dimitropulos, USA

What are the different way to achieve hemostasis after radial procedure? Is one superior to another?
Stamatis Dimitropulos, USA

Editorial Board Comments:

Tejas Patel:

I feel that Olivier Bertrand should give his inputs on it. He has designed one simple but a brilliant device. Along with his answer we will ask some good photos of device and how it works on the patients. Once we receive the reply, we immediately post it on the website.

Ian C. Gilchrist:

While we use the TR-Band, I actually believe it is not the tool but the application that matters. Anyway that you can apply enough pressure to stop bleeding but still allow distal perfusion via the radial artery will get a superior outcome – the so called “perfused hemostasis”. Whether you use a simple elastic support, hemobands, or fancier-more expensive equipment, you are paying for features and not necessarily results unless the technique or product is used correctly.

In our case, we initially used hemobands that were relatively inexpensive (and washable, too). But, despite repeated instruction, there was a desire for the staff to place these too tight and caused “handcuff injuries”. After one too many of these events, the hospital agreed to invest in more expensive product that was somewhat more forgiving.

I think the bottom line is technique for hemostasis is of prime importance. The tools you use are a secondary concern once you understand the importance of the technique.

Josef Ludwig:

We in Erlangen are conservative and tightfisted. We still use a tourniquet. And, we use it many times.

I was talking to Cordis two weeks ago to modify the exoseal device for radial. I used the 6F femoral three times and caused occlusion with the plug be inside the radial on sono. However, Cordis named me crazy and think there is no market in the US.

Reply by Ian C. Gilchirst:

There has never been any great genius without a spice of madness. “Nullum magnum ingenium sine mixtura dementiae fuit.”

De Tranquillitate Animi (XVII, 10)

We have heard that comment, “no market” for years. Some day it will be viewed as “missed opportunity”.

Yves Louvard::

I think the best way is a brief (150 minutes for 6F post PCI), monitored (patent radial artery), mechanic compression.

Well performed with the TR Band (Terumo).

We remove 2 cc every 20 minutes from the 15cc reservoir.

Mitchell W. Krucoff:

I agree with patent hemostasis absolutely, with a couple of caveats:

1. I am not a fan of added expense, but the controlled application pressure, adjustability and visibility of the TRI-band is unique and well worth     the cost.

2. Whatever system used, keeping pulse ox on the finger and testing radial patency by compressing the ulnar once the radial dressing is in     place is critical to ensuring flow during compression.

3. In some patients, patent hemostasis is simply not possible--if you allow radial flow they bleed, and if you compress enough to stop bleeding     they have no flow. So we still need some work and smart ideas to further advance optimal hemostasis devices.

My 2 cents!

David Hilton:

TR Band has replaced our old clamp in 99% of cases. Rarely because or other lines in the way we might still use the clamp we developed years ago.

Samir Pancholy:

I agree with Ian. Patent hemostasis using any device is superior to occlusive hemostatic pressure. And it does not increase bleeding complications.

Tak Kwan:

Absolutely true. Controlled hemostasis is the way to go.

Kintur Sanghvi:

Patent homeostasis, applying just enough pressure to achieve the homeostasis: is the way to go.
TR band in particular is very user friendly, easy to use for beginner, and the slow self-deflation of the pressure, theoretically may reduce radial occlusion.

At Saint Vincent we were using 4 gauze peaces and Elasto-plast. (very cheap technique) As one can not see the radial site, people have tendency to apply too much pressure because of the worry for homeostasis.

 
I need a better arm board to support the arm when doing radial interventions. Ours is too flexible even with arm moved to the patient's side. Do you have any specific ideas about size, material, where to get and how to use the arm board? Samual Butman, USA

I need a better arm board to support the arm when doing radial interventions. Ours is too flexible even with arm moved to the patient's side. Do you have any specific ideas about size, material, where to get and how to use the arm board?
Samual Butman, USA

Tift Mann

See enclosed "Mercedes"...note the table attachments for stability. this was the result of a graduate school project at our local engineering school. sweet!

Pictures:
 

We use TR Band and Radstat (Merit Medical) about 50:50. The latter is preferable with large wrists, patients who for whatever reason can't keep their wrist relatively still post procedure, and patients with small hematomas i.e. multiple sticks ( we use a larger homemade foam pad in this situation in place of the manufacturers small pad).

Editorial Board Comments:

Yves Louvard:

In Massy, France, we have a special bilateral arm support designed by one of our male nurse. We can use it for right radial approach of course but also for left radial with puncture on the left side of the patient.

Here is the system created by one of our male nurses, Patrice Cazabonne. Very effective, specially for left radial.

Video:

 
Pictures:
 
 
 
 
 
 
 

Ian C. Gilchrist

Similar to Dr. Louvard’s group, one of our cath lab technicians has designed a series of boards made with hard, transparent plastic that specifically hook into Siemen’s type tables. She has tried to get industry support for such devices but has been repeated turned down (typical response about lack of interest). The important design is to use material that is stiff, easy to clean, and not obstructive to radiation in case you need to angiogram the arm.

Attached is a picture of the Penn State-Hershey arm board (right side). Support for the arm and an area to hold things in the void between the arm and table. Very comfortable as one of our nurses is taking her break on it!

Josef Ludwig

We also do it like Yves does. Here are the pictures:

Howard A Cohan:

I only use the arm board when getting access - made of plywood. After access, I move the arm to the side with the arm held in place with the typical "L" shaped plastic arm holder used in patients who are undergoing femoral access. I swing the arm board under the mattress to help support the arm with the "L" shaped plastic holder only in obese patients. This works very well for me and is quite simple. HAC

David Hilton:

We just had our biomed take a rectangular piece of plexiglass and bend it. It slips under the mattress and the arm rests in the cuff it makes. It costs about $20 to make and we have one for each arm in all rooms so the patient doesn't need to support their arm whether it is the instrumented one or not.

Samir Pancholy:

We have a plexiglass rectangular board that partly goes under the patient projects out about 1 foot and gives platform space to park your tougher+manifold without sagging.

The left ARM if accessed we bring it over across patients belly to the right side.

Hildick Smith David:

We have also designed a radial board which incorporates a special radiation protection feature.

We haven’t had much joy from the companies though in trying to get this marketed.

Sanjay Shah:

We routinely use arm board made from acrylic or wood, which is not available commercially. It is 3’9” long; and 18” at its widest width and 6” at its narrowest width. I am attaching photograph of arm board.

Where can I get an arm board made for my cath lab, like the one shown by Tift Mann? Sanjay Srivatsa, USA

Comments:

Tift Mann:

The arm board shown was made by a group of engineering students from a local university and is not available commercially. Its unique feature is the table attachment which is nice but not absolutely necessary. For years we have used a 4' x 3.5' board made of 0.5" plexiglass simply slipped under the table mattress. A 3" curb is glued to the outside edge to help control catheters, etc. see attached picture:

Tak Kwan:

I took a picture of our arm board in Beth Israel Medical Center, New York. I ordered from OAKWORKS; it is a polycarbonate material; radiolucent, and easy to wash. We can cut it according to the figure.

 
Patient undergoing PCI, pre-treated with aspirin and clopidogrel, but also on warfarin. What do you do for anticoagulation (heparin, bivalirudin, Gp IIb/IIIa?) during the PCI if: Dr.Ian Gilchrist.

Patient undergoing PCI, pre-treated with aspirin and clopidogrel, but also on warfarin. What do you do for anticoagulation (heparin, bivalirudin, Gp IIb/IIIa?) during the PCI if:

1. INR is subtherapeutic?
2. INR is therapeutic?
3. INR is above therapeutic?

Dr. Ian Gilchrist.

Editorial Board Comments:

Mitchell W Krucoff:

TRI offers a better range of options than FA approach for patients on coumadin, however the potential need for conversion, IABP or urgent surgery cannot be eliminated entirely. For very elevated INR, the first question is "how urgent is it to proceed". On the other hand, for therapeutic range INR, TRI avoids delay during which time an elective patient might become unstable, and we routinely proceed with therapeutic INR for elective cases.

If INR is sub-therapeutic, we use antiplatelet and anticoagulation regimens same as patients not taking coumadin.

if INR is therapeutic, we use weight adjusted IV anti-coagulation, thienopyridine and asa.

if INR is super-therapeutic, for elective cases we use half-dose weight adjusted IV anti-coagulation, thienopyridine and asa.

Overall I routinely use bivalirudin as anti-coagulant of choice, adjusted by renal function. Efficacy is as good as combined IIb/IIIa and unfractionated heparin, very efficient for cath lab management, and very predictable post-procedure arteriotomy management without the costs of repeatedly drawing ACTs etc.

Yves Louvard:

For patients with this triple association I am doing what I do every day: 5000 UI of UFH to keep the radial patent and ACT to adapt for PCI (=300 sec).

To continue a triple association after PCI is another question (excess of stroke): I keep Plavix + Coumadin providing there is no Plavix resistance.

For me radial has very few limitations: LM, Bifurcations, AMI, and even CTO with 6F (sometimes 7) transradial. In case of IABP we reduce the number of femoral approach. if the patient has clopidogrel we don't use preventive GPIIb/IIIa - If absolutely necessary, an intra coronary bolus.

Josef Ludwig:

Irrespective of INR, clopidogrel and aspirin, 5, 000 units of heparin i.v as usual.

Since many yrs we give 5,000 of heparin i.v. Irrespective of INR values. But, I admit that elective cases in tiny, elderly pts I may rethink to wait or reduce heparin to 3,000 units. But, we (I, me, and myself) want do a complicated or sophisticated regimen and abandon the radial advantage. Our strategy never saw severe bleedings with 5,000 even not outside the wrist. In US lawers may not see it this way. That’s why for the upcoming radial country i.e., US the question is essential.

Tift Mann:

Being European influenced, I agree totally with Dr Ludwig. With bertrand's recent data, have been keeping act's @300 for PCI. The problem in US for transradial Intervention is our (their) commitment to the use of bival for trans-radial interventions.

Tak Kwan:

I will do the following for PCI:

1. INR is subtherapeutic: give heparin, bivalirudin, IbIIIa as usual.
2. INR is therapeutic: give heparin, bivalirudin, IIb IIIa as usual.
3. INR is above therapeutic: give heparin bivalirudin as usual, but extra careful with IIbIIIa or avoid it as long as pt is loaded with Plavix.

But if pt only for diagnostic cath and is on therapeutic or above therapeutic INR, I will not give heparin.

Samir Pancholy:

Agree with Tak's protocol.

Our data show that coumadin does not prevent radial artery occlusion as effectively as heparin.

I give 20 U/kg heparin for diagnostic procedures with INR 2-4

I do not do the procedure if INR is greater than 4.

Kintur Sanghvi:

I will do the following for PCI:
1. INR is subtherapeutic: give heparin or IIb/IIIA as usual. ACT>300
2. INR is therapeutic: give heparin,IIb IIIa as usual. ACT >250 3. INR is above therapeutic: give heparin only 50 U /kg. ACT >200. Be extra careful in using IIb/IIIA.

Bivalirudin: For Radialist there is no point in using Bivalurudin, as it is no way superior to Heparin except for reducing the bleeding incidences. Why would I waste health care dollars?

Working from radial we forget the bleeding complication. I would generally avoid a procedure with above therapeutic INR, unless in ACS situation. Because, if you end up getting a perforation, it will take a while based on your hospital situation to reverse the INR with FFP.
For diagnostic cath I will still use Heparin after the patent homeostasis protocol if the radial is not flowing.

I routinely aspirate 10 cc blood with force prior to removing the sheath, if I have not used any heparin.

Hildick Smith David:

Usually half dose heparin.

Tejas Patel:

Once again I am thankful to the members of international editorial board for such a prompt response. The question asked by Prof.Gilchrist represents a real world issue for which we have not arrived at consensus yet.

In our practice Sanjay and I observe the following protocol:

1.For patients with INR less than 3,we use our regular antiplatelet and anticoagulation protocol.We don’t hesitate using GP2b3a inhibitors as    and when required.

2.For INR patients between 3 and 5, we give half dose of heparin and avoid the use of GP2b3a inhibitors

3.For patients with INR above 5,we don’t give heparin and we avoid using GP2b3a inhibitors. If there is no emergency, we generally postpone    the procedure till INR drops to 3.

4.If INR is 3 or above and only coronary angiography is to be done, then we don’t use any anticoagulation.

 
Why is transulnar previous puncture a relative contraindication to transradial access? Victor Julio, Costa Rica

Why is transulnar previous puncture a relative contraindication to transradial access?
Victor Julio, Costa Rica

Editorial Board Comments:

Shigeru SAITO:
I don’t think the previous ulnar puncture is the contraindication for TRI, provided the ulnar artery is preserved.

Ian C. Gilchrist:
The status of either the radial or ulnar artery should be checked after it has been used to confirm antegrade flow. The palmar arch can provide enough collateral flow that simple palpation may not detect that the pulse is retrograde. Typically we place an oxygen saturation probe on the thumb and occlude the ulnar to check for radial artery flow. Likewise, if one occludes the radial artery, ulnar flow and the palmar arch flow can be confirmed from the probe on the thumb.

If the ulnar artery has been used, but still has antegrade flow, I would see no reason not to use the radial. Occlusions occur at the time of hemostasis and if antegrade flow is evident after hemostasis, then it is unlikely to disappear with time. On the other hand, if the ulnar artery is occluded with no antegrade flow, the use of the radial artery should be tempered with the understanding that this may represent the last major blood flow source to the hand. That certainly increases the risk that needs to be balanced against other possible entry sites.

Prof. Josef Ludwig:
If there is sufficient blood flow from ulnar to radial there will be no contras for TRA. However, it is forbidden to do radial immediately after failded ulnar access in the same session as an open ulnar cannot be proven at that time!

Sameer Pancholy:
I agree with Dr. Saito.If the ulnar was cannulated but abandoned due to adverse anatomy, I would not cannulate ipsilateral radial, for 24 hours.

Yves Louvard:
I won't puncture the ulnar after failure of the radial (<0,5% now) if I don't have a doppler assessment of patency of the radial.

I agree with all friends (but it was published!).

Josef Ludwig:
Yves. I understood the question was not puncture ulnar after radial failure. The question was vice versa. Nonetheless, it will remain the same. An frustran attack on one of the wrist arteries must have an evaluation of the patency, i.e., preserved dual blood flow to the hand. Anything else is bad Clinical practice

Yves is completely right, so far, that the radial is easier to asses. Hence, no need for ulnar. But, if you decide do ulnar, because of bad radial, it is mandatory to see the radial open. And of course vice versa.

David Hildick Smith:
Firstly, the transulnar approach is not a clever approach. It does not have the same benefits as the transradial as it lies deeper and is integrally associated with the ulnar nerve.

Yes, a previous transulnar approach is not necessarily an exclusion for a radial approach, but if you work in a region where the transulnar is used, this demands that you use the Allen’s test as a bare minimum to check the palmer arches, because if the ulnar is occluded and you occlude the radial, this can be bad news. Many centres have abandoned any assessment of the deep palmer arches as unreliable and simply do the transradial on all cases – this cannot be advocated in regions where the transulnar approach may already have been used….

David Hilton:
Not a very profound question has had an amazing response from everyone!! I agree with our British colleague's comments. I am not a fan of ulnar approach. Why not just use the other arm?

M. W. Krucoff:
1. Previous use of the ulnar artery could raise several concerns, especially to consider "why" the ulnar artery was used:
        a. Was there a complication or some other problem with the radial route that led to use of ulnar artery for previous procedure ?
        b. Was the Allen's test abnormal but the reverse Allen's ok Some insight could be gained by asking the patient whether they remember if             the radial side of wrist was punctured..

2. "Relative" contraindication is not absolute, thus we could consider use of the radial site depending on whether:
        a. how long ago was the ulnar puncture ?
        b. how has the ulnar artery healed (how is the ulnar pulsation) ?
        c. how does the radial pulse feel currently, and is the Allen's test normal or abnormal now ?

If the ulnar site has well healed and the Allen's test is normal, and there was no defineable complication with the radial route previously, then the radial puncture might be considered. For operators who tend to adopt the radial approach without using an Allen's test, I would suggest the Allen's test be specifically checked in a patient who has had previous trans-ulnar puncture.

Tejas Patel:
It has been a great discussion and the purpose of having transradialWORLD website is being served now. We are publishing this unedited discussion for benefit of all transradial intervention enthusiasts. My very sincere thanks to contributing international guest faculty.

Victor Julio Alfaro Obando
Thank you, I am very satisfied with the answer you gave to my questions. Of course, I will ask you other ones because I am a transradial interventionalist and in my country only 2 physicians practice transradial Approach. I have studied in Instituto Dante Pazzanesse de Cardiologia in Sao Paulo Brazil where I learned the transradial Approach. I appreciate your support.

 
How common is Reflex Sympathatic Dystrophy after radial catheterization? Kintur Sanghvi

How common is Reflex Sympathatic Dystrophy after radial catheterization?
Kintur Sanghvi

Reflex sympathetic dystrophy (complex regional pain syndrome, CRPS) is a very rare chronic pain condition. The syndrome is characterized by intense continuous pain out of proportion to the severity of the injury, continuous progression and deterioration of the symptoms. Typical features include intense burning pain or electrical sensations described as shooting pains. Patient may experience muscle spasm, local swelling, excessive sweating, change in the skin temperature and color, joint tenderness or stiffness restrictor or painful movements. Although the pathophysiology is unclear, the etiology is suspected to be either from sympathetic nervous system or from an immune response. Typically the syndrome involves one of the extremities. The syndrome complex is associated with vasomotor changes, and psychosocial disturbances also. Although this syndrome can happen at any age the mean age at diagnosis is 42.

Typically the syndrome has been described after traumatic injury, stroke and multiple different surgeries including Dupuytren's repair, tendon release procedures, knee surgery, crush injury, ankle arthrodesis, amputation, and hip arthroplasty, mastectomy etc. It is also been described after transbrachial catheterization. (1). CRPS is very rarely described as case report in literature following transradial catheterizations. (2,3) Injury from prolonged and aggressive homeostatic compression is probably the culprit. One of the report from 2002, the patient had 20 hours “Hemoband” application after the catheterization. (2) With the current practice of radial band / occlusive pressure application for a short period of 1-2 hours with just enough pressure to achieve homeostasis and the practice of patent homeostasis reduces the chances of this complication furthermore. (4)

Although there is no definitive curative measures, multiple different therapy options can be offered by a pain management specialist. Early recognition of the reflex sympathetic dystrophy and aggressive physical therapy has good outcomes. In the described case (3) report patient felt better and regain the function of right hand with therapy. For this reason post transradial catheterization, if the patient has pain persistent after first 3-7 days, patient should be evaluated by a physician for above symptoms or signs. If you suspected diagnosis of reflex sympathatic dystrophy referred the patient to pain specialist. Fortunately this complication is extremely rare complication, and in all of the other cases radial approach improves patient's quality of life and reduces discomfort.

(1) Inoue T, Yaguchi T, Mizoguchi K, Iwasaki Y, Takayanagi K, Morooka S, Asano S. Reflex sympathetic dystrophy following transbrachial cardiac catheterization. J Invas Cardiol 2000;12: 481–483.

(2) Papadimos TJ, Hofmann JP. Radial artery thrombosis, palmar arch systolic blood velocities, and chronic regional pain syndrome following transradial cardiac catheterization. Catheter Cardiovasc Interv. 2002;57:537-540.

(3) Complex Regional Pain Syndrome after Transradial Cardiac Catheterization. Chih-Jou Lai, Chen-Liang Chou, Tcho-Jen Liu, Rai-Chi Chan. Journal of the Chinese Medical Association April 2006 (Vol. 69, Issue 4, Pages 179-183).

(4) Prevention of radial artery occlusion - Patent hemostasis evaluation trial (PROPHET study): A randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Samir Pancholy, John Coppola, Tejas Patel, Marie Roke-Thomas. Catheterization and Cardiovascular Interventions ; 2008, 72: 335-340.

 
Sudden Problems with Spasm: Ian C. Gilchrist

Sudden Problems with Spasm?
Ian C. Gilchrist

We recently experienced increased problems with spasm in our cath lab for no apparent reason. No change in sheaths, antispasm medications, etc. Occurred whether we used 4F, 5F or 6F sheaths. What happened?

The .035" wire packaged with our angiography set up was changed from a Teflon coated wire to a non-coated wire, perhaps to save money. This uncoated wire appears to have been a coarser stimulant when in the radial/brachial artery causing spasm from its mechanical irritation of the vessel wall. Once this change was identified, we replaced these wires with the previously used coated wires and the mysterious out break of spasm disappeared.

One more thing to consider when spasm is a problem.

 
How does one overcome the radial loop? A tip for beginners...: Dr. Josef Ludwig

How does one overcome the radial loop? A tip for beginners…
Dr. Josef Ludwig

Radial artery loops are a prominent challenge in the transradial approach, especially for beginners. These loops increase with an aging population.

If you use the venous puncture technique and your 0.23" wire cannot be moved forward, stop and bring your venous canula into the radial artery in full size.

Inject contrast mixed with nitro (1:1). If you detect a loop, bring in a coronary extra support wire, not a floppy wire. In the majority of cases, the problem will be solved. If it is not, stop and try the other side (left radial). The venous canula is much smaller in size than a sheath and will make compression simple and radial damage unlikely.

When you succeed, retrieve the venous canula and insert your sheath over the extra support wire. This is the main advantage of an extra support wire contrary to a floppy wire, and is the advantage of venous puncture over bare needle puncture.

With the extra support wire on board, you can move forward a JR up to 6F into the aortic root.

 
The Technique of Transradial Carotid Stenting: Dr. Tift Mann

The Technique of Transradial Carotid Stenting
Dr. Tift Mann

Carotid stenting is performed transradially through a 6F shuttle sheath or Rabie catheter. The problem that must be surmounted is positioning the sheath in the common carotid across the acute angles that must be traversed from the arm approach. This is accomplished using a variation of the femoral technique of initially placing a diagnostic catheter into the external carotid artery. An exchange-length guide wire is then anchored in the external, and the diagnostic catheter is replaced with the shuttle sheath, which is positioned beneath the carotid bifurcation.

Bilateral carotid angiography is performed from the right radial artery with a 5F Simmons 1 diagnostic catheter. From the left radial, either a Simmons 1 or Tig (Terumo) catheter is used. After selection of the target carotid with the S1 catheter, a 0.14 inch extra support coronary guide wire or .025 inch angled glide wire is passed through the S1 catheter into the external carotid artery. A relatively soft guide wire is required to traverse the acute bend at the origin of the common carotid artery without dislodging the catheter, and we have had the most consistent success with a coronary guide wire. After advancing the diagnostic catheter into the external carotid, a stiff supportive wire is required to exchange for the shuttle sheath. From the right radial, a 260 cm .035 inch standard J guide wire provides adequate support for this exchange without creating excessive tension in the system. A .035” Amplatz Super stiff guide wire (Boston) or Supracore (Abbott) is used from left radial access. “Telescoping” a 5F right Judkins diagnostic catheter inside the shuttle sheath may be helpful in delivering the sheath to the common carotid. Carotid stenting is performed through the shuttle sheath using standard technique.

A major problem for the arm approach is inferior support for the shuttle sheath at the origin of the common carotid. Usually, the right subclavian artery or the first segment of the right common carotid artery has a transverse segment that provides a platform for the shuttle sheath. Similarly, there is usually sufficient support in cases involving a bovine left carotid artery, which is easily selected from the right arm with an Amplatz R2 catheter. In contrast, there is usually no inferior support for a shuttle sheath in cases involving the left common artery, and prolapse of the shuttle sheath into the ascending aorta may occur. Thus, transradial stenting of nonbovine left carotids is more difficult and procedural success rates are substantially lower.

All currently available carotid stents can be delivered through a 6F shuttle sheath, and selected carotid Wallstents can be delivered though 5F sheaths. However, caution must be observed during delivery since air can be introduced into the system creating the risk of air embolization. Using the “roadmap” fluoroscopy mode to position stents, as opposed to repeated contrast injections, will minimize this risk. Transradial experience is mandatory before undertaking these cases, and it is advisable to perform a few cases of carotid angiography alone before embarking on transradial stenting.

References

  1. Castriota F, Cremonesi A. Manetti R, Lamarra M. Noera G. Carotid stenting using radial artery access. J Endovasc Surg 1999; 6 : 385-386.

  2. Bendok BR, Przybylo JH, Parkinson R, et al. Neuroendovascular interventions for intracranial posterior circulation disease via the transradial approach: Technical case report. Neurosurgery 2005; 56: 626.

  3. Folmar J, Sachar R, Mann T. Transradial approach for carotid artery stenting: A feasibility study. Catheter Cardiovasc Interv 2007 ; 69 : 355-361.

  4. Pinter L, Cagiannos C, Ruzsa Z, Bakoyiannis C, Kolvenbach R. Report on initial experience with transradial access for carotid artery stenting. J Vasc Surg 2007; 45: 1136-1141.

  5. Patel T, Shah S, Ranian A, et al. Contralateral transradial approach for carotid artery stenting: A feasibility study. Catheter Cardiovas Interv. Early View (in press).

  6. Trani C, Burzotta F, and Coroleu F. Transradial carotid artery stenting with proximal embolic protection. Catheter Cardiovascular Interv. Early View (in press).
 
On the Dogma of Access Site: Complications During Primary Percutaneous Intervention in Acute Myocardial Infarction

On the Dogma of Access Site: Complications During Primary Percutaneous Intervention in Acute Myocardial Infarction
Dr. Josef Ludwig

Primary Percutaneous Intervention (PPCI) with stent implantation is the preferred modality to treat ST-segment elevation myocardial infarction (STEMI).  However, high success rates are often counterbalanced by severe bleeding at the femoral puncture site.

During the last decade, many investigators have compared TRA (transradial approach) vs. TFA (transfemoral approach) in STEMI in randomized- and non-randomized studies.

Louvard, et al. (2002) demonstrated in a large cohort of patients (n = 1,224; 185 TRA) in a prospective dual centre registry the benefit of TRA over TFA.  Success rates were similar in both cohorts (> 95% for both) and procedural time did not differ.  But severe access-site related bleeding was solely observed in TFA groups, despite using a femoral closure device in the majority of TFA patients (0% vs. 2% for closure device and 0% vs. 7% for manual compression).

Of interest, the TRA patients more often received 2B3A inhibitors; also, they had been given more antecedent thrombolysis.  These results have meanwhile been confirmed by many others worldwide.

Just to mention some of the trials: Saito, et al. (2003, Japan; n = 213; 77 TRA), Valsecchi, et al. (2003, Italy; n = 726; 163 TRA), Philippe, et al. (2004, France; n = 119; 64 TRA), Diaz de la Liera (2004, Spain; n = 162; 103 TRA), Ranjan, et al. (2005, India; n = 103), and Brasselet C, et al. (2007, France).

Recently, Ziakas, et al. (2007, Canada; >60-yrs; n = 155; 87 TRA), Yan, et al. (2008, China; >70-yrs; n = 103; 57 TRA), and Zimmermann, et al. (2009, Germany; >75-yrs; n = 115; 55 TRA) also converted the access-site benefit to elderly patients presenting with STEMI.

When taking all these trials together, it becomes obvious that, contrary to TFA, TRA has few, if any, severe access-site complications in PPCI for STEMI (<2%).  Therefore, it is justified to conclude that TRA for treatment of STEMI is feasible and safe, and superior to TFA when undertaken by experienced operators - in both young and old patients.  Ideally, any modern interventional centre around  the world should be able treat acute myocardial infarction by TRA for the benefit of their “high risk patients.”
 
 
What is the protocol for heparin dosage for the transradial procedure in your lab?

We had a recent case of a 74-year-old female patient suffering from angina on effort. Neither stress test bycicle ergometry, stress echo, sestamibi scintigraphy, nor stress MR were possible.

The decision was to perform angiography via the radial approach. We gave 5000 units of heparin intravenously because we were told from ICPS in France (Dr. Louvard; Dr. Lefevre) that 5000 units would reduce postprocedural radial artery closure.

Since heparin is an acid, we give it intravenously. I have recommended for two years not to administer heparin before the guide wire is in the aortic arch in case one must cross over to the femoral; or in case one perforates the radial or brachial artery, even if the latter is very rare.

Today this unlikely event happened and, because there was no heparin on board, the patient did well without any forearm problems. Thus, it is strongly suggested, especially for beginners, not to administer heparin before reaching the aortic arch.

Alternatively, heparin can also be administered via a catheter into the aorta, if you do not want to give it intravenously.

Dr. Joseph Ludwig
 
 
Forearm Venous Access: Utility, Tips & Tricks: Dr. Ian Gilchrist (May 2009)

Forearm Venous Access: Utility, Tips & Tricks
Dr. Ian Gilchrist

Transradial procedures do not need to be limited to the arterial system. The forearm, as shown in Figure 1, has a rich supply of veins that can be used as conduits to the heart for pulmonary artery catheterization (1-4), temporary pacemaker placement, myocardial biopsy (5), and other transvenous procedures. The technique is analogous to, but usually easier than, arterial access.

For efficiency in the laboratory, intravenous (IV) access is obtained in the pre-procedural area by the staff and capped to allow later needle puncture in the cath lab. While the antecubital veins may be most available, more distal veins can also be used. Using ultrasound, one can even identify deep veins that can be used if superficial veins are not present.

In the catheterization laboratory a small amount of local anesthesia is applied to the entry site to prevent pain and the cap on the intravenous catheter is punctured with the access needle. The wire for the introducer sheath is passed up the vein, the IV catheter is removed, and a vascular sheat is inserted. The wire and dilator are then removed from the sheath and it is flushed with saline. There is usually no need for antispasmodic medication, although NTG would be the agent of choice.

When passing a catheter up from the forearm, there are two primary courses the venous system may take. Veins on the medial (ulnar) side tend to coalesce into the basilic vein that continues as the axillary and subclavian. This is a very straight course that can be traversed usually without fluoroscopy.

Access from the radial side and some medial veins will pass laterally along the upper arm forming the cephalic vein that will then enter the axillary vein to form the subclavian vein. This cephalic/axillary junction may form a 90-degree "T" junction and raise some challenge to catheter passage. Do not push here against resistance. Watch under fluoroscopy or take a brief venogram to define the anatomy. A deep breath may alter the anatomic shape and allow passage. If these simple measures do not work, placing a hydrophilic wire through the catheter typically allows passage up the axillary vein and into the subclavian.

Once the catheter has reached the subclavian, it can be manipulated into the central venous position or passed through the right heart out into the pulmonary artery similarly to that done with central venous catheters placed via the usual routes. One must remember to deflate flow-directing balloons before pulling back into the smaller caliper veins, but otherwise no special precautions are necessary. At the conclusion of the procedure, the vascular sheath is removed and a pressure dressing is applied. Haemostatic devices used on the radial artery are not needed in the case of the low-pressure venous system. Overall, this is a very simple procedure that can significantly broaden one’s potential radial skills.

References

  1. Gilchrist IC, Moyer CD, Gascho JA. Trans-radial right and left heart catheterization: a comparison to traditional femoral approach. Cathet Cardiovasc Interv 2006;67:585-8.

  2. Cheng NJ, Ho WC, Ko YH, et al. Percutaneous cardiac catheterization combining direct venipuncture of superficial forearm veins and transradial arterial approach - A Feasible Approach. Acta Cardiol Sin 2003;19:159-64.

  3. Yang C-H, Guo B-F, Yip H-K, et al. Bilateral cardiac catheterization: The safety and feasibility of a superficial forearm venous and transradial arterial approach. International Heart Journal 2006;47:21-27.

  4. Lo TSN, Buch AN, Hall IR, Hildick-Smith DJ, Nolan J. Percutaneous left and right heart catheterization in fully anticoagulated patients utilizing the radial artery and forearm vein: A two-center experience. Journal of Interventional Cardiology 2006;19:258-263.

  5. Moyer CD, Gilchrist IC. Transradial bilateral-cardiac catheterization with endomyocardial biopsy: a feasibility study. Cathet Cardiovasc Interv 2005;64:134-137.
Figure 1: Veins of the forearm. (Adapted from Kimber DC, Gray CE. Anatomy and Physiology for Nurses-5th Ed, New York: Macmillian Company, 1919.)
 
 
Figure 2: Veins of the upper arm. (Adapted from Kimber DC, Gray CE. Anatomy and Physiology for Nurses-5th Ed, New York: Macmillian Company, 1919.)
 
 
 
The Transradial Approach to Bifurcation Lesions: Dr. Tak Kwan (May 2009)

The Transradial Approach to Bifurcation Lesions
Dr. Tak Kwan

Coronary bifurcation lesions occur in approximately 15% of all interventional cases. One-stent technique with provisional side-branch stenting is the preferred strategy for daily practice. However, in selected patients, especially in a large side branch, jeopardizing a large amount of myocardium may require a double-stent strategy. 

From transradial approach to bifurcation lesions, we routinely use a 6F sheath and a 6F large-lumen guiding catheter, e.g. Launcher, Metronic. For provisional stenting, we insert guidewires in both the main vessel and the side branch. The main vessel is stented with jailing the side branch guidewire. The radio-opaque marker of the jailed guidewire should be away from the stent to avoid the breakage of the guidewire. If there is a suboptimal result of the side-branch, then kissing balloon inflations of the main vessel and side branch can be performed by using two high-pressure monorail balloons, e.g. Quantum Maverick, Boston Scientific. If there is dissection or a suboptimal result of the side branch after kissing balloon inflations, perform a T-stent or TAP (T and Protusion) strategy.

Beside T-stent or TAP, other double-stenting techniques using a 6F large-lumen guide are Cullote or modified Crush technique. For Cullote technique, insert a stent in the side-branch first. Then perform balloon inflation through the main vessel strut, followed by main vessel stenting and final kissing balloon inflations. For a modified crush-stenting technique, predilate the side-branch lesion first. Then stent the side branch with a high-pressure balloon in the main vessel. After removing the balloon and guidewire from the side branch, crush the side-branch stent with the main vessel balloon. Then stent the main vessel, followed by final kissing balloon inflation. Many operators, including myself, do a double- kissing inflation before placing the main vessel stent.

For a 6F guiding system, the stent and balloon systems are monorail with the lowest profile possible, e.g. Taxus and Quantum Maverick from Boston Scientific. In some selected patients, you can use a 7F sheath and a 7F guiding catheter without difficulty.
 
 
The Transradial Approach for Bifurcation Stenting: Is it Feasible: Is it Useful? Dr. Yves Louvard (May 2009)

The Transradial Approach for Bifurcation Stenting: Is it Feasible, Is it Useful?
Dr. Yves Louvard

The radial artery has a mean diameter close to 2.9 mm (in France) which allows the use of 6F guiding catheters in the majority of cases (87% of cases), frequently 7F (76%), or even 8F. 

Nevertheless, 13% of vessels are too small for a 6F guiding (frequently in small women). In this case, it is still possible to use 5F guiding catheters; unfortunately, not compatible with a safe treatment of a bifurcation lesion. Sheathless catheters give a lumen of a 6F catheter with the external diameter close to 5F sheath; hydrophilic-guiding catheter allows slight oversizing of the catheter.

To perform safely a bifurcation stenting, a 6F lumen is big enough even for distal left main. Provisional side-branch (SB) stenting strategy is recognized today as the gold standard for treatment of bifurcation lesions after 6 randomized studies recently meta-analysed (Pan, Colombo, Nordic I and II, Bad Krozingen, Cactus, BBC One). This strategy consists in all types of bifurcation lesions (excepted Medina 0,0,1, the SB isolated ostial lesion) to insert 2 wires in the 2 branches, beginning with the most difficult branch in order to minimize the risk of twisting. The second step is normally a predilatation of the main branch, if necessary. We normally avoid predilating the SB. Then the main branch is stented across the SB with an adequate stent (maximal expansion and cell surface adapted to the treated vessel). A DES clearly reduces the risk of re-intervention. After stenting of the main vessel, the next steps are provisional: either the side branch is very small, patent, without pain and EKG change and the procedure is finished, or the SB is important and/or damaged and the two wires have to be exchanged to perform a kissing-balloon inflation. This kissing is performed with short balloons adapted to distal vessels in order to improve the results without stent distortion and also to give the proximal segment its own normal diameter. After kissing-balloon inflation when the result is poor in the SB (but take care angio and FFR are not giving the same results!)(BK. Koo study), a second stent can be deployed in the SB as a T stenting, Culotte, Internal Crush or TAP (T and Protrusion), followed by a new mandatory kissing-balloon inflation. This strategy is fully compatible with 6F transradial approach, even with 4 + 3.5 mm kissing balloon with some specific balloons (for example, Maverick). Recently it became possible to perform KB with non-compliant balloons through 6F (Hiryu balloons from Terumo). 

Some operators argue that in very complex lesions (those with a very long SB lesion) it is still necessary to perform complex techniques beginning with SB. Using the most recent comparison of techniques (randomised or not), we can say that the best are Culotte (beginning with MB or SB, better that Crush in Nordic II), double-kissing crush technique (or Sleeve, from Chen study), Minicrush (mini DK crush, from Galassi studies). 

Culotte technique and Crush technique have to be avoided when the angle between the two distal branches is widely opened. But don’t forget that the worst lesions can also be treated by elective T stenting technique beginning with the main branch. All these techniques can be performed through radial 6F approach! A classical Crush technique cannot!

In fact the only one technique which is not compatible with 6F, but can be performed with 7F (frequently possible transradially) is the SKS (simultaneous kissing stent, SK. Sharma). Nevertheless, this technique has not yet been randomly compared with other techniques in the same setting.

Why perform the transradial approach? Everyone knows! It is the preferred approach by patients (reduced bed rest, early ambulation, less vascular complications), by nurses (less patient care), by hospital directors, by insurance companies (outpatient coronary angiography and angioplasty are less expensive), and by doctors (fewer bleeding complications, fewer transfusions, and less mortality (MORTAL study).)

Bifurcation stenting: Keep it simple; do it transradially!
 
 
Physician, Do No Harm: The Transradial Approach

Physician, Do No Harm: The Transradial Approach
Dr. David Hilton

The concept of “Net Clinical Benefit” - efficacy minus safety - is now used widely in pharmaceutical trials.

This leads to a selection of treatments with the greatest clinical benefit for patients with coronary artery disease, whether we’re talking about stable angina, acute coronary syndrome, or acute myocardial infarction.

The same standard should be used throughout medicine, and specifically in the invasive approach to coronary artery disease, whether for diagnosis or treatment.

Focus on bleeding as a safety endpoint has been analyzed and shown to have a significant negative impact on patient outcomes, including an associated mortality that may greatly offset the initial proposed benefit.

The GRACE registry of coronary events, conducted between April 1999 and September 2002 in 94 hospitals, looked at 24,045 patients and found that the bleeding rate in patients treated invasively was 3.9%. (1) In an analysis of the OASIS Registry, OASIS-2, and CURE (N=34,146), John Eikelboom showed a strong mortality risk associated with bleeding; 2.5% without bleeding and a 5-times risk, or 12.5%, mortality with bleeding. (2)

In the ACUITY Trial, the mortality of those with a major bleed, rose from 1.2% to 7.3%. (3)  Recently, there has been much discussion about the Net Clinical Benefit of Prasugrel used in acute coronary syndrome as studied in the TRITON-TIMI 38 Trial, where the clinical benefit in the reduction of MACE and death and late stent thrombosis was offset by increased bleeding in certain populations. (4)

Radial access was first published by Dr. Campeau in 1989 in a study of the feasibility of this route to gain access to the coronaries for angiography. (5) Drs. Kiemeneij and Laarman followed in 1992 with the first reports of percutaneous intervention via the radial route. (6)

Since that time, there have been numerous reports documenting equivalence of outcome of the primary intervention, while at the same time having greater safety, mainly in the form of fewer access site complications. (7,8,9) This has led to discussion of patient preference, earlier ambulation, and lower cost. (10) These papers alone have not been enough to encourage much of the world to switch from the routine femoral approach to the radial approach, as there is a well- recognized learning curve, and it has not generally been perceived that the benefits were enough to have operators switch from femoral to radial.

Last year we published the British Columbia experience (11), involving over five years and 39,000 patients, of the difference that post- angioplasty transfusion had on mortality. The one-year mortality for those transfused was roughly 10 times that of the non-transfused. Mortality in transfused patients was 24% and the non-transfused mortality ranged between 2.5-3.5% (radial versus femoral). Importantly, however, access-site complications accounted for half of the total bleeds that needed to be transfused. 7,900 patients had a radial approach with a transfusion rate of 1.4 % versus 2.8%. This reduction of the need for transfusion by 50% therefore leads to a lower mortality on its own.

The concept of Net Clinical Benefit should apply to invasive procedures as well as medical studies. The efficacy of angioplasty is equivalent independent of access site, but the safety, when measured for mortality, is significantly greater using the radial approach.

The dictum “Physician Do No Harm,” from the Hippocratic Corpus thousands of years ago, is no less true today. There is now evidence of harm from the femoral approach that can be overcome simply by changing access site, and all physicians should endeavour to use this route whenever possible.

References

  1. Moscucci M, Fox KA, Cannon CP, Klein W, López-Sendón J, Montalescot G, White K, Goldberg RJ. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (Grace), Eur Heart J. 2003 Oct;24(20):1815-23.

  2. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006 Aug 22;114(8):774-82.

  3. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, King SB 3rd, Ohman EM, Stone GW. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol. 2007 Mar 27;49(12):1362-8.

  4. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007 Nov 15;357(20):2001-15.

  5. Campeau, L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn. 1989 Jan;16(1):3-7.

  6. Kiemeneij F, Laarman GJ, de Melker E. Transradial artery coronary angioplasty. Am Heart J. 1995 Jan;129(1):1-7.

  7. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol. 1997 May;29(6):1269-75.

  8. Cantor WJ, Mahaffey KW, Huang Z, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, Ferguson JJ, Califf RM, Goodman SG. Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radical access, smaller sheath sizes, and timely sheath removal; Catheter Cardiovascular Interv. 2007 Jan;69(1):73-83.

  9. Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, Slater J. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv. 2007 June 1;69(7):961-6.

  10. Ziakas A, Klinke P, Fretz E, Mildenberger R, Williams MB, Siega AD, Kinloch RD, Hilton JD. Same-day discharge is preferred by the majority of patients undergoing radial PCI. J Invasive Cardiol. 2004 Oct;16(10):562-5.

  11. Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, Berry B, Hilton JD. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L. study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart. 2008 Aug;94(8):1019-25.
 
The Transradial Approach to Renal and Iliac Stenting: Dr. John Coppola (February 2009)

The Transradial Approach to Renal and Iliac Stenting
Dr. John Coppola

Our approach to renal and iliac procedures is to use the left radial artery. 

In all but the tallest patients, this allows for selective conflation of the renal artery with a standard length coronary guiding catheter and the use of balloons and stents with a 135 cm shaft.

We use a standard 6F glide sheath for radial access and, using a .035 exchange length guide wire, enter the descending aorta. 

If difficulty is encountered entering the descending aorta, a LAO projection and a hydrophic-coated glide wire make the passage easier. 

Once at the level of L1, the guide wire is removed and the catheter is vigorously aspirated to prevent injection of atherosclerotic material into the renal artery.

The renal arteries tend to be oriented from the aorta in a direction that allows easy cannulation with a standard right Judkins guide or a multipurpose guide catheter.  The support from the upper extremity is very good and allows for easy passage of balloons and stents into the renal artery.

A non-hydrophic .014 guide wire is used.  Avoid hydrophic wires since they can lead to wire perforations. The lesion is often pre-dilated with an undersized balloon to avoid dissection and to allow for easier expansion of the stent.

The 6 mm balloon-expandable stents can pass without difficulty through a 6F guide; 7 mm or greater require a 7F guide catheter or a 6F guide sheath.

Multiple views are needed at times to ensure adequate coverage of the renal artery ostium.  If the patient complains of any back pain, stop and deflate the balloon.

A quick test shot is performed to rule out perforation or dissection.  At the completion of stenting, the guide catheter is removed over a .035 J tip wire to avoid trauma to the descending aorta or subclavian system.

The left-sided approach avoids the need to cross the aortic arch and saves 10-12 cm of catheter length, thus allowing the guide to reach the renal artery.

Iliac interventions are done in a similar fashion from the left radial artery. 

An introducer sheath is placed in the artery to allow for passage of a diagnostic catheter into the descending aorta.  This is then changed over a .035 exchange length wire for 90 cm hydrophilic coated sheaths (Terumo destination) or, in taller patients, a 110 cm Cook sheath. 

The lesion in the iliac artery is crossed with a wire, .014 or .035, and the iliac stenosis is pre-dilated with an undersized balloon. 

We prefer a balloon-expandable stent when working in the ostium of the iliac vessels, but use a self-expanding stent elsewhere. 

Since the size of the iliac vessels will quickly taper at times, the use of a self-expanding stent allows us to match the size of the stent to the vessel’s proximal large end without fear of dissection in the smaller segment, since the radial force exerted by these stents is low. 

After stent deployment, a balloon dilation is often performed to optimize the results.  The catheter is withdrawn over a .035 guide wire and local pressure is applied.

The radial approach allows for rapid ambulation and same day discharge, and avoids the use of a closure device in a diseased vessel or manual compression over a site just stented. 

With current self-expanding stents, stents with diameters of 14 mm can be placed via a 6F sheath.  Using balloon-expandable stents, maximal diameters of 8 mm are possible.

In very tall patients, a 125 cm diagnostic multipurpose catheter can be placed via the introducer sheath into each iliac artery and selective studies can be performed. 

The lesion can be marked using bony landmarks, and the guide wire can be placed across the lesion and the diagnostic catheter can be exchanged for a balloon or stent.
 
 
Radial Artery Occlusion: Myth, Prevention, and Treatment: Dr. Samir Pancholy (February 2009)

Radial Artery Occlusion: Myth, Prevention, and Treatment
Dr. Samir Pancholy

Radial artery occlusion (RAO) after transradial access (TRA) is one of the very few complications of TRA1. It has deterred some transfemoral operators from accepting TRA as their preferred access route.

The incidence of RAO ranges from 2-11% in the published literature. It is a thrombotic process that in a subset of patients leads to fibrotic occlusion. Administration of heparin has been shown to significantly reduce the incidence of RAO2, making heparin an integral part of the “radial cocktail.”

RAO is usually clinically quiescent and does not lead to limb-threatening ischemia. Pre-procedural confirmation of patency of palmar arches eliminates the clinical sequela of RAO.

MYTH: It is frequently argued that RAO is a reason not to use the radial artery as an access site. The truth is, RAO is not a frequently occurring complication and, with the new understanding of pathophysiology, its incidence can be further lowered to make it truly rare.

SUBSETS AT RISK: Patients with small-caliber radial arteries are at higher risk for RAO. Women, especially those with diabetes mellitus, tend to have a higher incidence of RAO. Heparin administration eliminates the predictive value of these demographic and morphologic variables, corroborating the fact that these patients are probably at higher risk for acute thrombotic occlusion after radial artery instrumentation. Occlusive pressure at the time of hemostatis is the most potent predictor of risk for RAO.

PREVENTION: RAO can be prevented by the administration of anticoagulation (heparin), with evidence suggesting a marked decrease (71% to 4%) in the incidence of RAO after administering 5000 units of heparin at the time of the procedure2. We have recently shown the efficacy of a “patent” hemostatic technique to further lower the incidence of RAO. These interventions do not increase hemorrhagic complications3.

TREATMENT: As RAO is almost always clinically quiescent, no active treatment is needed. The rare symptoms are from local thrombus that probably cause an inflammatory milieu, although limb-threatening ischemia after TRA has not been reported. If one encounters severe and unequivocal evidence of distal ischemia, surgical intervention should be considered. We have described a technique to reaccess the occluded radial artery to perform coronary procedures and have found a much lower incidence of reocclusion after the second procedure4. The reaccess technique may be used for symptomatic RAO patients.

TIPS:

  • Always use heparin during TRA if the patient does not have an unusual bleeding risk.
  • Use the smallest possible profile access sheath to complete the procedure.
  • Use universal patent hemostatic techniques. 
  1. Stella PR, Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty. Cathet Cardiovasc Diagn. 1997 Feb;40(2):156-8.
  2. Lefevre T, Thebault B, Spaulding C, Funck F, Chaveau M, Guillard N, Chalet Y, Bellorini M, Guerin F: Radial artery patency after percutaneous left radial artery approach for coronary angiography. The role of heparin.  Eur Heart J 16:293, 1995.
  3. Pancholy S, Coppola J, Patel T, Roke-Thomas M.
    Prevention of Radial Artery Occlusion—Patent Hemostasis Evaluation Trial (PROPHET Study): A Randomized Comparison of Traditional Versus Patency Documented Hemostasis After Transradial Catheterization. Catheterization and Cardiovascular Interventions 2008:72:335–340.
  4. Pancholy SB. Transradial access in an occluded radial artery: New Technique. J Invasive Cardiol.  2007 Dec; 19(12):541-4.
 
 
What is the best way to approach the transradial learning curve?

A learning curve precedes every new endeavor, but less effort is required if you keep the benefits in mind. Learning to play the piano is enjoyable when you remember the music you will be making.

Making medical procedures safe, comfortable, and cost-effective is our music. Finding a partner who is as excited as you are about the benefits of the transradial approach will make the learning curve less lonely.

In the beginning, select patients with large wrists and well-palpable radial pulses. Avoid elderly (over age 70), hypertensive patients since they often have an elongated aortic arch and a tortuous subclavian system.

As you perfect the puncture technique and the cannulation of the coronary arteries, you can move on to smaller wrists, weaker pulses, and more interesting subclavian systems.

In the beginning, prepare the femoral area to increase your comfort level. In our experience, it takes about 200 cases to overcome the initial challenges of the transradial approach.
 
 
How does the radiation exposure with the transradial approach compare to that of the transfemoral approach?

All beginning interventional cardiologists face a relatively higher level of radiation when they are training. Once they pass the learning curve, radiation exposure is minimized.

Although one study has shown higher radiation exposures for radial operators as compared to femoral operators, we have found that this is only a problem in hospitals where the patient's arm is kept perpendicular to the table. The proximity of the X-ray tube increases radiation exposure. At our Cath Lab and at many other hospitals, the arm is kept parallel to the table.

When the radial puncture site is lower than the femoral puncture site, the question of a higher radiation exposure does not arise.

Second, our Cath Lab uses Optitorque TIG (Terumo) catheters for diagnostic procedures— left ventricular angiograms and left and right coronary cannulation. Because there is no need to use three catheters and there is no catheter exchange-related radiation exposure, the radial operator has an advantage over the femoral operator.

Third, whether the radial or the femoral route is used, interventional procedures are the same. When the radial operator is well-versed in the tricks of catheter maneuvering, radiation exposure is a non-issue.
 
 
What about radial-artery occlusion?

Radial-artery occlusion is rare and has no clinical consequences. It is seen in 3% to 6% of cases. Limb-threatening ischemia has never been documented.

Short procedure time, an adequate dose of heparin, and immediate removal of the sheath after the procedure are key in preventing radial-artery occlusion.
 
 
Can devices other than balloons and stents be used in the transradial approach?

Most radial arteries are able to accommodate 6F catheters. The 6F large-lumen catheters have an inner diameter of at least 0.070" which allows the use of distal-protection devices using PercuSurge or filter wire.

The 6F catheter also allows bifurcation stenting and the use of extraction catheters. Because most rotablation is now performed for lesion modification and not debulking, large burrs are rarely used. One can easily use a 1.75 mm and even a 2.0 mm rotablator burr through a 6F large-lumen guiding catheter that can be placed transradially in most patients.

Except for patients of short stature, 7F guiding catheters can also be used transradially. The bottom line is that the transradial approach does not limit device use.
 
 
Can the radial route be used to treat infradiaphragmatic lesions (i.e., renal, iliac, superficial femoral)?

For patients who are shorter than 160 cm, regular-length catheters can be used through the right-radial route for renal interventions. For taller patients, it is better to use the left-radial approach and to puncture the radial artery higher. This eliminates about 10 to 12 cm of length from the arch of the aorta and another 8 to 10 cm from the length of the forearm.

So infradiaphragmatic lesions can be approached with the usual hardware. However, 125 cm long catheters are available for diagnostic and interventional procedures. Long-shaft balloons and stents are also available.
 
 
Can a radial artery that has been used for a transradial procedure be used as a bypass graft?

There are several issues regarding using a radial artery for CABG surgery.

The conclusions of three major studies from the United States, the United Kingdom, and Australia have raised major concerns about the usefulness and patency of the radial artery even over the saphenous vein graft.

LIMA grafts are unquestionably the preferred conduit. Arterial grafts are generally preferred over venous grafts because it is assumed that medium-sized arteries are less prone to atherosclerosis. This is true for the LIMA, but it is not true for the radial artery.

In our own study (results to be published soon), we were surprised to find atherosclerosis and calcification in native radial arteries harvested during the CABG procedures performed at our hospital.

Moreover, if radial artery grafting is needed, the contralateral radial artery is always available. It is the usual practice to use the right radial artery for percutaneous procedures and the left radial artery for bypass grafts.

The fact the the transradial procedure induces intimal proliferation has been documented in one study, so cardiac surgeons should use the left radial artery if they are forced to use a radial conduit.
 
 
The new femoral-closure devices allow early ambulation.  So what is the advantage to using the transradial approach?

Although early ambulation is possible with the latest femoral-closure devices, local vascular complication rates remain high. According to a recent meta-analysis of all major trials (with over 42,000 patients), the complication rates for femoral-closure devices were even higher than for manual compression.

So the advantage of early ambulation with the new femoral-closure devices comes with an increased risk of local vascular complications.

The transradial approach allows early ambulation (the "Walk In, Walk Out" benefit) and even minor vascular complications are extremely rare. Moreover, it is inexpensive; femoral-closure devices can add $250 to the cost of the procedure.
 
 
What is the status of the transulnar approach? How do you compare it with the transradial approach?

Several small feasibility studies establishing the safety of the transulnar approach have been published. A major feasibility study and a major randomized study comparing the transulnar approach with the transradial approach are needed.

We have begun working through this approach and hope to shed more light on this subject soon.

The usual observation is that the ulnar artery has a larger diameter and a straighter course than the radial artery. These would seem to be two major advantages.

The downside is that the ulnar artery is more deeply seated, making the puncture difficult. And the ulnar nerve passes near the ulnar artery at the usual puncture site, increasing the possibility of accidental nerve damage. It is also true that the chance of post-procedure hematoma could be slightly higher because of the ulnar artery's depth. A large study is needed to evaluate these issues.
 
 
Why isn't the transradial approach more popular in the United States?

The primary reason transradial intervention is not usually the approach of choice in the United States is due to lack of adequate exposure during Fellowship training.

American interventionalists also feel they do not need to learn more about the transradial approach because they already know how to cannulate the radial artery.

Transradial intervention is considered a "bail-out" technique so it is not performed frequently enough for skills to be maintained.

Finally, it takes approximately 200 cases to work through the initial learning curve and most solo US interventionalists do not have the annual volume to master the approach.

Just like anywhere else, these things create a "generation gap" where already-practicing interventionalists who are not able to perform front-line transradial intervention become critics of the procedure—exaggerating its difficulty and imagining its complications.
 
 
   
 
  ABOUT US

ABOUT TRI

TRICO COURSE

TRICO FELLOWSHIP

SPONSORS

USEFUL LINKS

 
TCVS
TRICO
Editorial Board
What is it?
 
History/Mission
Testimonials
Case Archive
Photos
TRICO 2010
Mission
Testimonials
Case Archive
Photos
TRICO 2010 Information
Fellows' Feedback
Application
Sponsors Links
© 2010 Transradialworld, All rights reserved.